NAME	ORIGINAL SIZE	AFTER RESTRICTING TO DATASET	STATUS	
ABBUD_LIF_SIGNALING_1_DN	28	23		
ABBUD_LIF_SIGNALING_1_UP	43	40		
ABBUD_LIF_SIGNALING_2_DN	7		Rejected!	
ABBUD_LIF_SIGNALING_2_UP	13		Rejected!	
ABDELMOHSEN_ELAVL4_TARGETS	16	16		
ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	13		Rejected!	
ABE_INNER_EAR	43	34		
ABE_VEGFA_TARGETS	19	17		
ABE_VEGFA_TARGETS_2HR	35	33		
ABE_VEGFA_TARGETS_30MIN	29	26		
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	20	20		
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	26	26		
ABRAMSON_INTERACT_WITH_AIRE	44	44		
ACEVEDO_LIVER_CANCER_DN	540	499		
ACEVEDO_LIVER_CANCER_UP	972		Rejected!	
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	222	185		
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	290	246		
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	119	113		
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	139	109		
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	274	250		
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	863		Rejected!	
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	873		Rejected!	
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	354	330		
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	173	159		
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	116	114		
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	84	82		
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	74	74		
AFFAR_YY1_TARGETS_DN	260	233		
AFFAR_YY1_TARGETS_UP	199	181		
AGARWAL_AKT_PATHWAY_TARGETS	11		Rejected!	
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	237	232		
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	303	290		
AIGNER_ZEB1_TARGETS	35	31		
AIYAR_COBRA1_TARGETS_DN	29	28		
AIYAR_COBRA1_TARGETS_UP	40	37		
AKL_HTLV1_INFECTION_DN	69	69		
AKL_HTLV1_INFECTION_UP	27	27		
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	186	184		
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	140	136		
ALCALA_APOPTOSIS	87	85		
ALFANO_MYC_TARGETS	239	230		
ALONSO_METASTASIS_DN	26	25		
ALONSO_METASTASIS_EMT_DN	5		Rejected!	
ALONSO_METASTASIS_EMT_UP	35	32		
ALONSO_METASTASIS_NEURAL_UP	18	17		
ALONSO_METASTASIS_UP	194	180		
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	125	120		
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	107	106		
AMIT_DELAYED_EARLY_GENES	18	18		
AMIT_EGF_RESPONSE_120_HELA	68	67		
AMIT_EGF_RESPONSE_120_MCF10A	41	41		
AMIT_EGF_RESPONSE_20_HELA	12		Rejected!	
AMIT_EGF_RESPONSE_20_MCF10A	12		Rejected!	
AMIT_EGF_RESPONSE_240_HELA	59	58		
AMIT_EGF_RESPONSE_240_MCF10A	21	21		
AMIT_EGF_RESPONSE_40_HELA	42	42		
AMIT_EGF_RESPONSE_40_MCF10A	17	17		
AMIT_EGF_RESPONSE_480_HELA	164	162		
AMIT_EGF_RESPONSE_480_MCF10A	43	40		
AMIT_EGF_RESPONSE_60_HELA	47	45		
AMIT_EGF_RESPONSE_60_MCF10A	39	39		
AMIT_SERUM_RESPONSE_120_MCF10A	65	63		
AMIT_SERUM_RESPONSE_20_MCF10A	17	16		
AMIT_SERUM_RESPONSE_240_MCF10A	57	52		
AMIT_SERUM_RESPONSE_40_MCF10A	32	32		
AMIT_SERUM_RESPONSE_480_MCF10A	39	34		
AMIT_SERUM_RESPONSE_60_MCF10A	58	56		
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53	16	16		
AMUNDSON_RESPONSE_TO_ARSENITE	219	211		
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	64	56		
ANDERSEN_CHOLANGIOCARCINOMA_CLASS1	63	55		
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2	175	159		
ANDERSEN_LIVER_CANCER_KRT19_DN	75	66		
ANDERSEN_LIVER_CANCER_KRT19_UP	35	22		
APPEL_IMATINIB_RESPONSE	33	33		
APPIERTO_RESPONSE_TO_FENRETINIDE_DN	51	51		
APPIERTO_RESPONSE_TO_FENRETINIDE_UP	38	35		
APRELIKOVA_BRCA1_TARGETS	48	47		
ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	43	42		
ASTIER_INTEGRIN_SIGNALING	58	51		
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	160	156		
ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	49	48		
AUJLA_IL22_AND_IL17A_SIGNALING	11		Rejected!	
AUNG_GASTRIC_CANCER	52	47		
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN	18	17		
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	126	117		
AZARE_STAT3_TARGETS	24	22		
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	52	50		
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	25	22		
BAELDE_DIABETIC_NEPHROPATHY_DN	437	430		
BAELDE_DIABETIC_NEPHROPATHY_UP	89	85		
BAE_BRCA1_TARGETS_DN	30	29		
BAE_BRCA1_TARGETS_UP	71	70		
BAFNA_MUC4_TARGETS_UP	5		Rejected!	
BAKER_HEMATOPOESIS_STAT1_TARGETS	10		Rejected!	
BAKER_HEMATOPOESIS_STAT5_TARGETS	7		Rejected!	
BAKER_HEMATOPOIESIS_STAT3_TARGETS	15	15		
BAKKER_FOXO3_TARGETS_DN	176	166		
BAKKER_FOXO3_TARGETS_UP	55	54		
BALDWIN_PRKCI_TARGETS_UP	40	39		
BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION	13		Rejected!	
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	33	31		
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP	9		Rejected!	
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	160	143		
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	19	17		
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN	9		Rejected!	
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP	14		Rejected!	
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	32	31		
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	18	16		
BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_DN	20	17		
BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP	20	19		
BARIS_THYROID_CANCER_DN	59	58		
BARIS_THYROID_CANCER_UP	24	24		
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	31	31		
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	33	31		
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	12		Rejected!	
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16		Rejected!	
BARRIER_COLON_CANCER_RECURRENCE_DN	19	19		
BARRIER_COLON_CANCER_RECURRENCE_UP	42	42		
BASAKI_YBX1_TARGETS_DN	398	390		
BASAKI_YBX1_TARGETS_UP	294	287		
BASSO_B_LYMPHOCYTE_NETWORK	146	141		
BASSO_CD40_SIGNALING_DN	71	71		
BASSO_CD40_SIGNALING_UP	103	102		
BASSO_HAIRY_CELL_LEUKEMIA_DN	6		Rejected!	
BASSO_HAIRY_CELL_LEUKEMIA_UP	79	77		
BAUS_TFF2_TARGETS_DN	12		Rejected!	
BAUS_TFF2_TARGETS_UP	32	27		
BECKER_TAMOXIFEN_RESISTANCE_DN	54	52		
BECKER_TAMOXIFEN_RESISTANCE_UP	54	50		
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3	7		Rejected!	
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	46	42		
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	59	59		
BEIER_GLIOMA_STEM_CELL_DN	67	66		
BEIER_GLIOMA_STEM_CELL_UP	40	35		
BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE	48	48		
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	29	28		
BENPORATH_CYCLING_GENES	648		Rejected!	
BENPORATH_EED_TARGETS	1059		Rejected!	
BENPORATH_ES_1	379	364		
BENPORATH_ES_2	40	39		
BENPORATH_ES_CORE_NINE	9		Rejected!	
BENPORATH_ES_CORE_NINE_CORRELATED	100	95		
BENPORATH_ES_WITH_H3K27ME3	1115		Rejected!	
BENPORATH_MYC_MAX_TARGETS	775		Rejected!	
BENPORATH_MYC_TARGETS_WITH_EBOX	230	213		
BENPORATH_NANOG_TARGETS	988		Rejected!	
BENPORATH_NOS_TARGETS	179	166		
BENPORATH_OCT4_TARGETS	290	274		
BENPORATH_PRC2_TARGETS	650		Rejected!	
BENPORATH_PROLIFERATION	147	145		
BENPORATH_SOX2_TARGETS	734		Rejected!	
BENPORATH_SUZ12_TARGETS	1035		Rejected!	
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN	48	48		
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP	29	26		
BERENJENO_TRANSFORMED_BY_RHOA_DN	398	386		
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	29	27		
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP	20	18		
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN	30	29		
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP	8		Rejected!	
BERENJENO_TRANSFORMED_BY_RHOA_UP	549		Rejected!	
BERGER_MBD2_TARGETS	5		Rejected!	
BERNARD_PPAPDC1B_TARGETS_DN	59	57		
BERNARD_PPAPDC1B_TARGETS_UP	37	37		
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	46	41		
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	24	24		
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	180	175		
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	207	206		
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	126	113		
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	122	118		
BHATTACHARYA_EMBRYONIC_STEM_CELL	84	75		
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	88	87		
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	211	204		
BHAT_ESR1_TARGETS_VIA_AKT1_DN	82	80		
BHAT_ESR1_TARGETS_VIA_AKT1_UP	281	270		
BIDUS_METASTASIS_DN	154	150		
BIDUS_METASTASIS_UP	221	218		
BILANGES_RAPAMYCIN_SENSITIVE_GENES	37	30		
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	69	60		
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	69	28		
BILANGES_SERUM_RESPONSE_TRANSLATION	34	19		
BILANGES_SERUM_SENSITIVE_GENES	80	71		
BILANGES_SERUM_SENSITIVE_VIA_TSC1	21	18		
BILANGES_SERUM_SENSITIVE_VIA_TSC2	32	30		
BILBAN_B_CLL_LPL_DN	41	41		
BILBAN_B_CLL_LPL_UP	64	64		
BILD_CTNNB1_ONCOGENIC_SIGNATURE	79	76		
BILD_E2F3_ONCOGENIC_SIGNATURE	248	242		
BILD_HRAS_ONCOGENIC_SIGNATURE	251	243		
BILD_MYC_ONCOGENIC_SIGNATURE	210	207		
BILD_SRC_ONCOGENIC_SIGNATURE	59	59		
BLALOCK_ALZHEIMERS_DISEASE_DN	1248		Rejected!	
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	166	154		
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	389	375		
BLALOCK_ALZHEIMERS_DISEASE_UP	1671		Rejected!	
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN	216	180		
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP	378	368		
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN	187	180		
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP	644		Rejected!	
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN	81	74		
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP	137	135		
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN	59	53		
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	144	130		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN	96	90		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN	76	69		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP	486	462		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP	545		Rejected!	
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN	77	64		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP	86	80		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_DN	24	17		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP	339	318		
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN	14		Rejected!	
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP	174	164		
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN	175	175		
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	174	168		
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	123	111		
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP	204	196		
BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN	118	112		
BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP	41	39		
BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_DN	37	34		
BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP	299	292		
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN	119	103		
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP	286	272		
BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_DN	9		Rejected!	
BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP	12		Rejected!	
BLUM_RESPONSE_TO_SALIRASIB_DN	341	336		
BLUM_RESPONSE_TO_SALIRASIB_UP	245	240		
BOCHKIS_FOXA2_TARGETS	433	402		
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	33	32		
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	31	24		
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	38	38		
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	46	44		
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	92	86		
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	22	22		
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	31	31		
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	237	229		
BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	505	490		
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN	31	28		
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	428	414		
BOQUEST_STEM_CELL_DN	218	216		
BOQUEST_STEM_CELL_UP	262	244		
BORCZUK_MALIGNANT_MESOTHELIOMA_DN	106	99		
BORCZUK_MALIGNANT_MESOTHELIOMA_UP	310	303		
BORLAK_LIVER_CANCER_EGF_UP	53	50		
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	150	148		
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	69	55		
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	78	78		
BOSCO_TH1_CYTOTOXIC_MODULE	114	107		
BOUDOUKHA_BOUND_BY_IGF2BP2	108	97		
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	17	17		
BOWIE_RESPONSE_TO_TAMOXIFEN	18	18		
BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	51	47		
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	47	44		
BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	15		Rejected!	
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	40	38		
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	40	40		
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	116	111		
BOYAULT_LIVER_CANCER_SUBCLASS_G2	28	28		
BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN	10		Rejected!	
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	53	53		
BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	53	51		
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	190	188		
BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17	16		
BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	11		Rejected!	
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	28	28		
BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	19	19		
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	66	65		
BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1	12		Rejected!	
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN	32	32		
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	36	36		
BOYLAN_MULTIPLE_MYELOMA_C_DN	59	57		
BOYLAN_MULTIPLE_MYELOMA_C_D_DN	276	270		
BOYLAN_MULTIPLE_MYELOMA_C_D_UP	140	137		
BOYLAN_MULTIPLE_MYELOMA_C_UP	49	46		
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN	37	37		
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP	27	25		
BOYLAN_MULTIPLE_MYELOMA_D_DN	81	80		
BOYLAN_MULTIPLE_MYELOMA_D_UP	90	87		
BOYLAN_MULTIPLE_MYELOMA_PCA1_DN	9		Rejected!	
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	123	118		
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN	71	68		
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP	82	78		
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	42	40		
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP	26	26		
BRACHAT_RESPONSE_TO_CISPLATIN	23	22		
BRACHAT_RESPONSE_TO_METHOTREXATE_DN	26	25		
BRACHAT_RESPONSE_TO_METHOTREXATE_UP	24	24		
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	58	56		
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP	65	65		
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN	41	41		
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP	52	51		
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	15	15		
BRIDEAU_IMPRINTED_GENES	65	58		
BROCKE_APOPTOSIS_REVERSED_BY_IL6	146	144		
BROWNE_HCMV_INFECTION_10HR_DN	57	56		
BROWNE_HCMV_INFECTION_10HR_UP	98	95		
BROWNE_HCMV_INFECTION_12HR_DN	100	96		
BROWNE_HCMV_INFECTION_12HR_UP	112	110		
BROWNE_HCMV_INFECTION_14HR_DN	290	274		
BROWNE_HCMV_INFECTION_14HR_UP	156	154		
BROWNE_HCMV_INFECTION_16HR_DN	83	78		
BROWNE_HCMV_INFECTION_16HR_UP	223	220		
BROWNE_HCMV_INFECTION_18HR_DN	182	169		
BROWNE_HCMV_INFECTION_18HR_UP	172	169		
BROWNE_HCMV_INFECTION_1HR_DN	218	200		
BROWNE_HCMV_INFECTION_1HR_UP	51	46		
BROWNE_HCMV_INFECTION_20HR_DN	102	99		
BROWNE_HCMV_INFECTION_20HR_UP	235	230		
BROWNE_HCMV_INFECTION_24HR_DN	145	141		
BROWNE_HCMV_INFECTION_24HR_UP	146	143		
BROWNE_HCMV_INFECTION_2HR_DN	48	44		
BROWNE_HCMV_INFECTION_2HR_UP	40	37		
BROWNE_HCMV_INFECTION_30MIN_DN	145	127		
BROWNE_HCMV_INFECTION_30MIN_UP	54	47		
BROWNE_HCMV_INFECTION_48HR_DN	482	444		
BROWNE_HCMV_INFECTION_48HR_UP	180	174		
BROWNE_HCMV_INFECTION_4HR_DN	252	237		
BROWNE_HCMV_INFECTION_4HR_UP	50	48		
BROWNE_HCMV_INFECTION_6HR_DN	164	157		
BROWNE_HCMV_INFECTION_6HR_UP	63	57		
BROWNE_HCMV_INFECTION_8HR_DN	48	43		
BROWNE_HCMV_INFECTION_8HR_UP	105	100		
BROWNE_INTERFERON_RESPONSIVE_GENES	67	67		
BROWN_MYELOID_CELL_DEVELOPMENT_DN	133	129		
BROWN_MYELOID_CELL_DEVELOPMENT_UP	167	157		
BRUECKNER_TARGETS_OF_MIRLET7A3_DN	76	73		
BRUECKNER_TARGETS_OF_MIRLET7A3_UP	110	101		
BRUINS_UVC_RESPONSE_EARLY_LATE	316	305		
BRUINS_UVC_RESPONSE_LATE	1135		Rejected!	
BRUINS_UVC_RESPONSE_MIDDLE	99	93		
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A	900		Rejected!	
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B	554		Rejected!	
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C	91	86		
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	279	258		
BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS	8		Rejected!	
BRUNEAU_SEPTATION_ATRIAL	5		Rejected!	
BRUNEAU_SEPTATION_VENTRICULAR	10		Rejected!	
BRUNO_HEMATOPOIESIS	67	65		
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN	22	22		
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP	21	21		
BUFFA_HYPOXIA_METAGENE	50	46		
BURTON_ADIPOGENESIS_1	31	31		
BURTON_ADIPOGENESIS_10	31	31		
BURTON_ADIPOGENESIS_11	52	50		
BURTON_ADIPOGENESIS_12	32	32		
BURTON_ADIPOGENESIS_2	71	69		
BURTON_ADIPOGENESIS_3	100	100		
BURTON_ADIPOGENESIS_4	45	42		
BURTON_ADIPOGENESIS_5	118	110		
BURTON_ADIPOGENESIS_6	191	184		
BURTON_ADIPOGENESIS_7	49	48		
BURTON_ADIPOGENESIS_8	80	79		
BURTON_ADIPOGENESIS_9	84	80		
BURTON_ADIPOGENESIS_PEAK_AT_0HR	64	63		
BURTON_ADIPOGENESIS_PEAK_AT_16HR	41	38		
BURTON_ADIPOGENESIS_PEAK_AT_24HR	44	43		
BURTON_ADIPOGENESIS_PEAK_AT_2HR	45	45		
BURTON_ADIPOGENESIS_PEAK_AT_8HR	39	39		
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN	647		Rejected!	
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	822		Rejected!	
BYSTROEM_CORRELATED_WITH_IL5_DN	60	60		
BYSTROEM_CORRELATED_WITH_IL5_UP	41	39		
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	68	62		
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS	157	145		
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3	8		Rejected!	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1	8		Rejected!	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA	9		Rejected!	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	132	126		
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS	783		Rejected!	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1	8		Rejected!	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS	27	23		
BYSTRYKH_SCP2_QTL	6		Rejected!	
CADWELL_ATG16L1_TARGETS_DN	68	64		
CADWELL_ATG16L1_TARGETS_UP	103	91		
CAFFAREL_RESPONSE_TO_THC_24HR_3_DN	13		Rejected!	
CAFFAREL_RESPONSE_TO_THC_24HR_3_UP	8		Rejected!	
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	56	56		
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	33	32		
CAFFAREL_RESPONSE_TO_THC_8HR_3_DN	10		Rejected!	
CAFFAREL_RESPONSE_TO_THC_8HR_3_UP	5		Rejected!	
CAFFAREL_RESPONSE_TO_THC_8HR_5_DN	12		Rejected!	
CAFFAREL_RESPONSE_TO_THC_8HR_5_UP	15	15		
CAFFAREL_RESPONSE_TO_THC_DN	32	31		
CAFFAREL_RESPONSE_TO_THC_UP	32	31		
CAIRO_HEPATOBLASTOMA_CLASSES_DN	214	201		
CAIRO_HEPATOBLASTOMA_CLASSES_UP	612		Rejected!	
CAIRO_HEPATOBLASTOMA_DN	267	241		
CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	16		Rejected!	
CAIRO_HEPATOBLASTOMA_UP	213	208		
CAIRO_LIVER_DEVELOPMENT_DN	225	205		
CAIRO_LIVER_DEVELOPMENT_UP	166	158		
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN	13		Rejected!	
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	22	22		
CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP	5		Rejected!	
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN	5		Rejected!	
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP	5		Rejected!	
CAMPS_COLON_CANCER_COPY_NUMBER_DN	74	63		
CAMPS_COLON_CANCER_COPY_NUMBER_UP	93	77		
CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB	14		Rejected!	
CARD_MIR302A_TARGETS	77	73		
CARRILLOREIXACH_14Q32OVEREXPRESSION_IN_HEPATOBLASTOMA	48		Rejected!	
CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN	1257		Rejected!	
CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPERMETHYLATED_AND_DN	21	21		
CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP	162	149		
CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP	893		Rejected!	
CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN	168	163		
CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_UP	52	45		
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	669		Rejected!	
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	173	169		
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	39	39		
CASTELLANO_HRAS_AND_NRAS_TARGETS_DN	8		Rejected!	
CASTELLANO_HRAS_AND_NRAS_TARGETS_UP	6		Rejected!	
CASTELLANO_HRAS_TARGETS_DN	6		Rejected!	
CASTELLANO_HRAS_TARGETS_UP	5		Rejected!	
CASTELLANO_NRAS_TARGETS_DN	14		Rejected!	
CASTELLANO_NRAS_TARGETS_UP	72	69		
CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	32	26		
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN	33	32		
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP	19	18		
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY	41	32		
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY	40	27		
CERVERA_SDHB_TARGETS_1_DN	36	33		
CERVERA_SDHB_TARGETS_1_UP	120	115		
CERVERA_SDHB_TARGETS_2	115	105		
CHANDRAN_METASTASIS_DN	313	297		
CHANDRAN_METASTASIS_TOP50_DN	44	43		
CHANDRAN_METASTASIS_TOP50_UP	37	37		
CHANDRAN_METASTASIS_UP	209	203		
CHANGOLKAR_H2AFY_TARGETS_DN	42	41		
CHANGOLKAR_H2AFY_TARGETS_UP	49	46		
CHANG_IMMORTALIZED_BY_HPV31_DN	60	54		
CHANG_IMMORTALIZED_BY_HPV31_UP	73	69		
CHANG_POU5F1_TARGETS_DN	8		Rejected!	
CHANG_POU5F1_TARGETS_UP	15		Rejected!	
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	52	52		
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	126	113		
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	456	439		
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	384	371		
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	465	453		
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	454	428		
CHASSOT_SKIN_WOUND	9		Rejected!	
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	106	103		
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	50	50		
CHEBOTAEV_GR_TARGETS_DN	125	114		
CHEBOTAEV_GR_TARGETS_UP	77	72		
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN	5		Rejected!	
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	20	16		
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	408	389		
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	145	143		
CHENG_IMPRINTED_BY_ESTRADIOL	110	102		
CHENG_RESPONSE_TO_NICKEL_ACETATE	45	45		
CHENG_TAF7L_TARGETS	6		Rejected!	
CHEN_ETV5_TARGETS_SERTOLI	25	21		
CHEN_ETV5_TARGETS_TESTIS	25	22		
CHEN_HOXA5_TARGETS_6HR_DN	6		Rejected!	
CHEN_HOXA5_TARGETS_6HR_UP	10		Rejected!	
CHEN_HOXA5_TARGETS_9HR_DN	42	42		
CHEN_HOXA5_TARGETS_9HR_UP	223	220		
CHEN_LIVER_METABOLISM_QTL_CIS	95	89		
CHEN_LUNG_CANCER_SURVIVAL	28	26		
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	42	39		
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	102	97		
CHEN_METABOLIC_SYNDROM_NETWORK	1243		Rejected!	
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	50	47		
CHEN_PDGF_TARGETS	18	18		
CHEOK_RESPONSE_TO_HD_MTX_DN	23	23		
CHEOK_RESPONSE_TO_HD_MTX_UP	23	22		
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	25	25		
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP	5		Rejected!	
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	20	20		
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP	10		Rejected!	
CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	21	21		
CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	12		Rejected!	
CHESLER_BRAIN_D6MIT150_QTL_CIS	6		Rejected!	
CHESLER_BRAIN_D6MIT150_QTL_TRANS	9		Rejected!	
CHESLER_BRAIN_HIGHEST_EXPRESSION	41	40		
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	38	36		
CHESLER_BRAIN_QTL_CIS	73	69		
CHESLER_BRAIN_QTL_TRANS	6		Rejected!	
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	170	166		
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	175	160		
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	52	47		
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	26	22		
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	25	25		
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	79	70		
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	179	160		
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	179	174		
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	194	186		
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	86	83		
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	152	149		
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	120	111		
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	53	50		
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP	59	56		
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	141	140		
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	128	121		
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	68	67		
CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	30	30		
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	19	19		
CHIBA_RESPONSE_TO_TSA	45	45		
CHIBA_RESPONSE_TO_TSA_DN	21	21		
CHIBA_RESPONSE_TO_TSA_UP	50	45		
CHICAS_RB1_TARGETS_CONFLUENT	566		Rejected!	
CHICAS_RB1_TARGETS_GROWING	242	237		
CHICAS_RB1_TARGETS_LOW_SERUM	103	97		
CHICAS_RB1_TARGETS_SENESCENT	565		Rejected!	
CHIN_BREAST_CANCER_COPY_NUMBER_DN	13		Rejected!	
CHIN_BREAST_CANCER_COPY_NUMBER_UP	28	24		
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	30	30		
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	54	24		
CHOI_ATL_ACUTE_STAGE	6		Rejected!	
CHOI_ATL_CHRONIC_VS_ACUTE_DN	19	19		
CHOI_ATL_STAGE_PREDICTOR	44	44		
CHOW_RASSF1_TARGETS_DN	30	30		
CHOW_RASSF1_TARGETS_UP	26	26		
CHO_NR4A1_TARGETS	32	28		
CHUANG_OXIDATIVE_STRESS_RESPONSE_DN	11		Rejected!	
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	28	26		
CHUNG_BLISTER_CYTOTOXICITY_DN	50	49		
CHUNG_BLISTER_CYTOTOXICITY_UP	136	133		
CHYLA_CBFA2T3_TARGETS_DN	246	236		
CHYLA_CBFA2T3_TARGETS_UP	388	376		
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	35	34		
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP	20	19		
CLAUS_PGR_POSITIVE_MENINGIOMA_DN	12		Rejected!	
CLAUS_PGR_POSITIVE_MENINGIOMA_UP	10		Rejected!	
CLIMENT_BREAST_CANCER_COPY_NUMBER_DN	8		Rejected!	
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	23	21		
COATES_MACROPHAGE_M1_VS_M2_DN	84	81		
COATES_MACROPHAGE_M1_VS_M2_UP	86	85		
COLDREN_GEFITINIB_RESISTANCE_DN	229	218		
COLDREN_GEFITINIB_RESISTANCE_UP	86	86		
COLINA_TARGETS_OF_4EBP1_AND_4EBP2	359	343		
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	28	27		
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	34	31		
COLLER_MYC_TARGETS_DN	7		Rejected!	
COLLER_MYC_TARGETS_UP	24	24		
COLLIS_PRKDC_REGULATORS	13		Rejected!	
COLLIS_PRKDC_SUBSTRATES	17	17		
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	176	167		
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	239	229		
CONRAD_GERMLINE_STEM_CELL	13		Rejected!	
CONRAD_STEM_CELL	39	37		
CORONEL_RFX7_DIRECT_TARGETS_UP	44	44		
CORRE_MULTIPLE_MYELOMA_DN	59	57		
CORRE_MULTIPLE_MYELOMA_UP	79	74		
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	138	131		
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	109	102		
COWLING_MYCN_TARGETS	43	41		
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	23	21		
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	34	34		
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	534	500		
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	471	457		
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	727		Rejected!	
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	307	293		
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	491	477		
CROMER_METASTASIS_DN	77	75		
CROMER_METASTASIS_UP	73	69		
CROMER_TUMORIGENESIS_DN	49	39		
CROMER_TUMORIGENESIS_UP	58	50		
CROONQUIST_IL6_DEPRIVATION_DN	95	95		
CROONQUIST_IL6_DEPRIVATION_UP	17	16		
CROONQUIST_NRAS_SIGNALING_DN	70	70		
CROONQUIST_NRAS_SIGNALING_UP	40	38		
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	97	95		
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	41	41		
CROONQUIST_STROMAL_STIMULATION_DN	13		Rejected!	
CROONQUIST_STROMAL_STIMULATION_UP	56	54		
CROSBY_E2F4_TARGETS	6		Rejected!	
CUI_GLUCOSE_DEPRIVATION	61	59		
CUI_TCF21_TARGETS_2_DN	850		Rejected!	
CUI_TCF21_TARGETS_2_UP	433	412		
CUI_TCF21_TARGETS_DN	34	31		
CUI_TCF21_TARGETS_UP	36	34		
CURSONS_NATURAL_KILLER_CELLS	20	20		
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	34	32		
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	28	27		
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN	9		Rejected!	
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP	14		Rejected!	
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	466	465		
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	75	75		
DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	856		Rejected!	
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	84	83		
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	59	56		
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	318	308		
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	85	85		
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	25	23		
DAIRKEE_CANCER_PRONE_RESPONSE_BPA	51	50		
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	118	110		
DAIRKEE_CANCER_PRONE_RESPONSE_E2	28	27		
DALESSIO_TSA_RESPONSE	26	19		
DANG_BOUND_BY_MYC	1061		Rejected!	
DANG_MYC_TARGETS_DN	31	31		
DANG_MYC_TARGETS_UP	130	113		
DANG_REGULATED_BY_MYC_DN	251	245		
DANG_REGULATED_BY_MYC_UP	68	68		
DARWICHE_PAPILLOMA_PROGRESSION_RISK	77	68		
DARWICHE_PAPILLOMA_RISK_HIGH_DN	185	171		
DARWICHE_PAPILLOMA_RISK_HIGH_UP	154	135		
DARWICHE_PAPILLOMA_RISK_LOW_DN	172	156		
DARWICHE_PAPILLOMA_RISK_LOW_UP	168	151		
DARWICHE_SKIN_TUMOR_PROMOTER_DN	194	174		
DARWICHE_SKIN_TUMOR_PROMOTER_UP	147	132		
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	186	169		
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	153	137		
DASU_IL6_SIGNALING_DN	7		Rejected!	
DASU_IL6_SIGNALING_SCAR_DN	16		Rejected!	
DASU_IL6_SIGNALING_SCAR_UP	31	30		
DASU_IL6_SIGNALING_UP	61	59		
DAUER_STAT3_TARGETS_DN	48	48		
DAUER_STAT3_TARGETS_UP	48	43		
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	179	168		
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	340	324		
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	20	19		
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	60	57		
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	14		Rejected!	
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	64	59		
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	66	62		
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	258	246		
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	26	26		
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP	13		Rejected!	
DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	59	49		
DAZARD_RESPONSE_TO_UV_NHEK_DN	300	295		
DAZARD_RESPONSE_TO_UV_NHEK_UP	223	200		
DAZARD_RESPONSE_TO_UV_SCC_DN	115	114		
DAZARD_RESPONSE_TO_UV_SCC_UP	105	105		
DAZARD_UV_RESPONSE_CLUSTER_G1	62	48		
DAZARD_UV_RESPONSE_CLUSTER_G2	30	30		
DAZARD_UV_RESPONSE_CLUSTER_G24	24	22		
DAZARD_UV_RESPONSE_CLUSTER_G28	20	20		
DAZARD_UV_RESPONSE_CLUSTER_G3	14		Rejected!	
DAZARD_UV_RESPONSE_CLUSTER_G4	20	19		
DAZARD_UV_RESPONSE_CLUSTER_G5	12		Rejected!	
DAZARD_UV_RESPONSE_CLUSTER_G6	145	144		
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	276	274		
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	300	294		
DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS	21	18		
DELACROIX_RARG_BOUND_MEF	366	348		
DELACROIX_RAR_BOUND_ES	465	435		
DELACROIX_RAR_TARGETS_DN	26	24		
DELACROIX_RAR_TARGETS_UP	47	44		
DELASERNA_MYOD_TARGETS_DN	56	56		
DELASERNA_MYOD_TARGETS_UP	86	82		
DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4	11		Rejected!	
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	21	20		
DELPUECH_FOXO3_TARGETS_DN	40	39		
DELPUECH_FOXO3_TARGETS_UP	65	63		
DELYS_THYROID_CANCER_DN	233	225		
DELYS_THYROID_CANCER_UP	445	426		
DEMAGALHAES_AGING_DN	16	16		
DEMAGALHAES_AGING_UP	54	54		
DEN_INTERACT_WITH_LCA5	26	26		
DER_IFN_ALPHA_RESPONSE_DN	6		Rejected!	
DER_IFN_ALPHA_RESPONSE_UP	74	73		
DER_IFN_BETA_RESPONSE_DN	8		Rejected!	
DER_IFN_BETA_RESPONSE_UP	103	102		
DER_IFN_GAMMA_RESPONSE_DN	11		Rejected!	
DER_IFN_GAMMA_RESPONSE_UP	71	70		
DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	22	22		
DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	159	141		
DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	155	142		
DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	242	237		
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	323	322		
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	367	340		
DE_YY1_TARGETS_DN	93	92		
DE_YY1_TARGETS_UP	20	18		
DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN	116	103		
DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP	1399		Rejected!	
DIERICK_SEROTONIN_FUNCTION_GENES	7		Rejected!	
DING_LUNG_CANCER_BY_MUTATION_RATE	20	19		
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	100	97		
DING_LUNG_CANCER_MUTATED_FREQUENTLY	12		Rejected!	
DING_LUNG_CANCER_MUTATED_RECURRENTLY	6		Rejected!	
DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	26	23		
DIRMEIER_LMP1_RESPONSE_EARLY	62	58		
DIRMEIER_LMP1_RESPONSE_LATE_DN	30	23		
DIRMEIER_LMP1_RESPONSE_LATE_UP	56	55		
DISTECHE_ESCAPED_FROM_X_INACTIVATION	13		Rejected!	
DITTMER_PTHLH_TARGETS_DN	70	65		
DITTMER_PTHLH_TARGETS_UP	113	113		
DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC	27	25		
DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED	17	15		
DOANE_BREAST_CANCER_CLASSES_DN	33	30		
DOANE_BREAST_CANCER_CLASSES_UP	72	66		
DOANE_BREAST_CANCER_ESR1_DN	47	37		
DOANE_BREAST_CANCER_ESR1_UP	111	99		
DOANE_RESPONSE_TO_ANDROGEN_DN	242	235		
DOANE_RESPONSE_TO_ANDROGEN_UP	184	174		
DODD_NASOPHARYNGEAL_CARCINOMA_DN	1405		Rejected!	
DODD_NASOPHARYNGEAL_CARCINOMA_UP	1813		Rejected!	
DONATO_CELL_CYCLE_TRETINOIN	6		Rejected!	
DORMOY_ELAVL1_TARGETS	18	17		
DORN_ADENOVIRUS_INFECTION_12HR_DN	33	33		
DORN_ADENOVIRUS_INFECTION_12HR_UP	28	24		
DORN_ADENOVIRUS_INFECTION_24HR_DN	42	40		
DORN_ADENOVIRUS_INFECTION_24HR_UP	12		Rejected!	
DORN_ADENOVIRUS_INFECTION_32HR_DN	38	36		
DORN_ADENOVIRUS_INFECTION_32HR_UP	11		Rejected!	
DORN_ADENOVIRUS_INFECTION_48HR_DN	39	36		
DORN_ADENOVIRUS_INFECTION_48HR_UP	14		Rejected!	
DORSAM_HOXA9_TARGETS_DN	32	32		
DORSAM_HOXA9_TARGETS_UP	35	34		
DORSEY_GAB2_TARGETS	30	29		
DOUGLAS_BMI1_TARGETS_DN	314	309		
DOUGLAS_BMI1_TARGETS_UP	563		Rejected!	
DUAN_PRDM5_TARGETS	77	69		
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	19	19		
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	53	53		
DURAND_STROMA_NS_UP	169	157		
DURAND_STROMA_S_UP	300	282		
DURCHDEWALD_SKIN_CARCINOGENESIS_DN	265	253		
DURCHDEWALD_SKIN_CARCINOGENESIS_UP	96	89		
DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	504	494		
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	323	317		
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	91	88		
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	228	219		
DUTTA_APOPTOSIS_VIA_NFKB	33	32		
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	48	44		
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	49	43		
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	200	187		
EGUCHI_CELL_CYCLE_RB1_TARGETS	22	22		
EHLERS_ANEUPLOIDY_DN	12		Rejected!	
EHLERS_ANEUPLOIDY_UP	40	38		
EHRLICH_ICF_SYNDROM_DN	17	16		
EHRLICH_ICF_SYNDROM_UP	13		Rejected!	
EINAV_INTERFERON_SIGNATURE_IN_CANCER	27	27		
ELLWOOD_MYC_TARGETS_DN	43	42		
ELLWOOD_MYC_TARGETS_UP	13		Rejected!	
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN	105	103		
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	41	41		
ELVIDGE_HIF1A_TARGETS_DN	92	91		
ELVIDGE_HIF1A_TARGETS_UP	67	66		
ELVIDGE_HIF2A_TARGETS_UP	6		Rejected!	
ELVIDGE_HYPOXIA_BY_DMOG_DN	59	59		
ELVIDGE_HYPOXIA_BY_DMOG_UP	133	127		
ELVIDGE_HYPOXIA_DN	147	145		
ELVIDGE_HYPOXIA_UP	172	166		
ENGELMANN_CANCER_PROGENITORS_DN	69	62		
ENGELMANN_CANCER_PROGENITORS_UP	48	46		
ENK_UV_RESPONSE_EPIDERMIS_DN	512	491		
ENK_UV_RESPONSE_EPIDERMIS_UP	296	277		
ENK_UV_RESPONSE_KERATINOCYTE_DN	481	477		
ENK_UV_RESPONSE_KERATINOCYTE_UP	533	490		
EPPERT_CE_HSC_LSC	41	40		
EPPERT_HSC_R	127	123		
EPPERT_LSC_R	42	42		
EPPERT_PROGENITOR	138	137		
FAELT_B_CLL_WITH_VH3_21_DN	49	49		
FAELT_B_CLL_WITH_VH3_21_UP	45	45		
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	49	47		
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	48	48		
FALVELLA_SMOKERS_WITH_LUNG_CANCER	81	74		
FARDIN_HYPOXIA_11	32	32		
FARDIN_HYPOXIA_9	7		Rejected!	
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	329	313		
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL	327	311		
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	329	316		
FARMER_BREAST_CANCER_CLUSTER_1	48	48		
FARMER_BREAST_CANCER_CLUSTER_2	33	32		
FARMER_BREAST_CANCER_CLUSTER_3	16	15		
FARMER_BREAST_CANCER_CLUSTER_4	19	17		
FARMER_BREAST_CANCER_CLUSTER_5	19	19		
FARMER_BREAST_CANCER_CLUSTER_6	14		Rejected!	
FARMER_BREAST_CANCER_CLUSTER_7	20	18		
FARMER_BREAST_CANCER_CLUSTER_8	7		Rejected!	
FERNANDEZ_BOUND_BY_MYC	181	169		
FERRANDO_HOX11_NEIGHBORS	23	22		
FERRANDO_LYL1_NEIGHBORS	16	16		
FERRANDO_TAL1_NEIGHBORS	20	20		
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	89	86		
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	89	88		
FERRARI_RESPONSE_TO_FENRETINIDE_DN	5		Rejected!	
FERRARI_RESPONSE_TO_FENRETINIDE_UP	22	22		
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN	96	91		
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	164	155		
FEVR_CTNNB1_TARGETS_DN	555		Rejected!	
FEVR_CTNNB1_TARGETS_UP	688		Rejected!	
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN	46	44		
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP	122	115		
FIGUEROA_AML_METHYLATION_CLUSTER_2_DN	9		Rejected!	
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP	54	49		
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	40	37		
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP	170	158		
FIGUEROA_AML_METHYLATION_CLUSTER_4_DN	15	15		
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	112	108		
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN	47	39		
FIGUEROA_AML_METHYLATION_CLUSTER_5_UP	12		Rejected!	
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN	37	32		
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP	140	134		
FIGUEROA_AML_METHYLATION_CLUSTER_7_DN	5		Rejected!	
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP	118	112		
FINAK_BREAST_CANCER_SDPP_SIGNATURE	26	24		
FINETTI_BREAST_CANCERS_KINOME_BLUE	21	20		
FINETTI_BREAST_CANCERS_KINOME_GRAY	15	15		
FINETTI_BREAST_CANCER_KINOME_GREEN	16	16		
FINETTI_BREAST_CANCER_KINOME_RED	16	16		
FIRESTEIN_CTNNB1_PATHWAY	32	32		
FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION	9		Rejected!	
FIRESTEIN_PROLIFERATION	166	161		
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS	311	298		
FISCHER_DREAM_TARGETS	969		Rejected!	
FISCHER_G1_S_CELL_CYCLE	200	198		
FISCHER_G2_M_CELL_CYCLE	236	236		
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	24	22		
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	568		Rejected!	
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	553		Rejected!	
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	88	88		
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	42	42		
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	153	143		
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	51	48		
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	65	65		
FLORIO_HUMAN_NEOCORTEX	47	41		
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	190	188		
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP	384	344		
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	31	29		
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	52	34		
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	70	68		
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	78	73		
FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	80	70		
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	66	63		
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	26	25		
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	38	36		
FOROUTAN_INTEGRATED_TGFB_EMT_DN	74	67		
FOROUTAN_INTEGRATED_TGFB_EMT_UP	120	116		
FOROUTAN_PRODRANK_TGFB_EMT_DN	82	78		
FOROUTAN_PRODRANK_TGFB_EMT_UP	185	181		
FOROUTAN_TGFB_EMT_DN	108	101		
FOROUTAN_TGFB_EMT_UP	192	188		
FORTSCHEGGER_PHF8_TARGETS_DN	783		Rejected!	
FORTSCHEGGER_PHF8_TARGETS_UP	278	268		
FOSTER_KDM1A_TARGETS_DN	202	193		
FOSTER_KDM1A_TARGETS_UP	263	224		
FOSTER_TOLERANT_MACROPHAGE_DN	413	410		
FOSTER_TOLERANT_MACROPHAGE_UP	166	161		
FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN	6		Rejected!	
FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	20	20		
FOURNIER_ACINAR_DEVELOPMENT_LATE_2	281	276		
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	22	21		
FOURNIER_ACINAR_DEVELOPMENT_LATE_UP	11		Rejected!	
FRASOR_RESPONSE_TO_ESTRADIOL_DN	78	73		
FRASOR_RESPONSE_TO_ESTRADIOL_UP	35	33		
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	49	48		
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	23	23		
FRASOR_TAMOXIFEN_RESPONSE_DN	12		Rejected!	
FRASOR_TAMOXIFEN_RESPONSE_UP	51	48		
FREDERICK_PRKCI_TARGETS	10		Rejected!	
FRIDMAN_IMMORTALIZATION_DN	33	33		
FRIDMAN_SENESCENCE_DN	13		Rejected!	
FRIDMAN_SENESCENCE_UP	77	76		
FUJII_YBX1_TARGETS_DN	194	193		
FUJII_YBX1_TARGETS_UP	43	40		
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN	8		Rejected!	
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP	11		Rejected!	
FUJIWARA_PARK2_IN_LIVER_CANCER_UP	8		Rejected!	
FUKUSHIMA_TNFSF11_TARGETS	16	15		
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	457	451		
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP	587		Rejected!	
FUNG_IL2_SIGNALING_1	10		Rejected!	
FUNG_IL2_SIGNALING_2	12		Rejected!	
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES	7		Rejected!	
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1	9		Rejected!	
FURUKAWA_DUSP6_TARGETS_PCI35_DN	73	71		
FURUKAWA_DUSP6_TARGETS_PCI35_UP	73	67		
FU_INTERACT_WITH_ALKBH8	13		Rejected!	
GABRIELY_MIR21_TARGETS	289	286		
GAJATE_RESPONSE_TO_TRABECTEDIN_DN	20	20		
GAJATE_RESPONSE_TO_TRABECTEDIN_UP	66	65		
GALE_APL_WITH_FLT3_MUTATED_DN	16	16		
GALE_APL_WITH_FLT3_MUTATED_UP	59	59		
GALIE_TUMOR_ANGIOGENESIS	8		Rejected!	
GALIE_TUMOR_STEMNESS_GENES	6		Rejected!	
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	79	78		
GALI_TP53_TARGETS_APOPTOTIC_DN	6		Rejected!	
GALI_TP53_TARGETS_APOPTOTIC_UP	8		Rejected!	
GALLUZZI_PERMEABILIZE_MITOCHONDRIA	41	41		
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	14		Rejected!	
GAL_LEUKEMIC_STEM_CELL_DN	236	229		
GAL_LEUKEMIC_STEM_CELL_UP	130	125		
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	168	156		
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	50	50		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN	11		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	35	35		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	62	61		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	139	139		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP	16		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP	17	17		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	24	24		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	26	26		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	80	77		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	18	18		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN	8		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP	11		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN	12		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	28	28		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN	34	33		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN	13		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	26	26		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	16	15		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN	15	15		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN	11		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	56	56		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	83	83		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	23	23		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	32	32		
GARY_CD5_TARGETS_DN	440	425		
GARY_CD5_TARGETS_UP	473	469		
GAURNIER_PSMD4_TARGETS	73	68		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	95	91		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	195	186		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN	8		Rejected!	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	27	25		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN	23	22		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	174	165		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN	10		Rejected!	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	38	36		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	22	21		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	98	88		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	35	34		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	184	173		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	34	33		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	244	222		
GAUTSCHI_SRC_SIGNALING	8		Rejected!	
GAVIN_FOXP3_TARGETS_CLUSTER_P2	81	78		
GAVIN_FOXP3_TARGETS_CLUSTER_P3	161	159		
GAVIN_FOXP3_TARGETS_CLUSTER_P4	100	98		
GAVIN_FOXP3_TARGETS_CLUSTER_P6	93	91		
GAVIN_FOXP3_TARGETS_CLUSTER_P7	91	88		
GAVIN_FOXP3_TARGETS_CLUSTER_T4	97	97		
GAVIN_FOXP3_TARGETS_CLUSTER_T7	101	96		
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN	5		Rejected!	
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP	19	19		
GAVIN_PDE3B_TARGETS	22	22		
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	470	452		
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	26	26		
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	41	34		
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	30	30		
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	66	64		
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	39	39		
GAZIN_EPIGENETIC_SILENCING_BY_KRAS	25	24		
GEISS_RESPONSE_TO_DSRNA_DN	16	15		
GEISS_RESPONSE_TO_DSRNA_UP	39	39		
GENTILE_RESPONSE_CLUSTER_D3	53	53		
GENTILE_UV_HIGH_DOSE_DN	289	285		
GENTILE_UV_HIGH_DOSE_UP	23	22		
GENTILE_UV_LOW_DOSE_DN	64	64		
GENTILE_UV_LOW_DOSE_UP	25	25		
GENTILE_UV_RESPONSE_CLUSTER_D1	17	17		
GENTILE_UV_RESPONSE_CLUSTER_D2	38	36		
GENTILE_UV_RESPONSE_CLUSTER_D4	54	54		
GENTILE_UV_RESPONSE_CLUSTER_D5	35	35		
GENTILE_UV_RESPONSE_CLUSTER_D6	35	34		
GENTILE_UV_RESPONSE_CLUSTER_D7	37	37		
GENTILE_UV_RESPONSE_CLUSTER_D8	37	37		
GENTILE_UV_RESPONSE_CLUSTER_D9	26	26		
GENTLES_LEUKEMIC_STEM_CELL_DN	19	18		
GENTLES_LEUKEMIC_STEM_CELL_UP	29	29		
GEORGES_CELL_CYCLE_MIR192_TARGETS	62	62		
GEORGES_TARGETS_OF_MIR192_AND_MIR215	892		Rejected!	
GERHOLD_ADIPOGENESIS_DN	62	59		
GERHOLD_ADIPOGENESIS_UP	48	47		
GERHOLD_RESPONSE_TO_TZD_DN	13		Rejected!	
GERHOLD_RESPONSE_TO_TZD_UP	6		Rejected!	
GERY_CEBP_TARGETS	130	124		
GESERICK_TERT_TARGETS_DN	21	21		
GHANDHI_BYSTANDER_IRRADIATION_DN	12		Rejected!	
GHANDHI_BYSTANDER_IRRADIATION_UP	84	79		
GHANDHI_DIRECT_IRRADIATION_DN	35	32		
GHANDHI_DIRECT_IRRADIATION_UP	105	99		
GHO_ATF5_TARGETS_DN	16	16		
GHO_ATF5_TARGETS_UP	13		Rejected!	
GILDEA_METASTASIS	29	28		
GILMORE_CORE_NFKB_PATHWAY	13		Rejected!	
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	184	182		
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	110	106		
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	336	330		
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	69	67		
GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN	117	116		
GLINSKY_CANCER_DEATH_UP	7		Rejected!	
GNATENKO_PLATELET_SIGNATURE	44	43		
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION	43	41		
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	1087		Rejected!	
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	575		Rejected!	
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS	13		Rejected!	
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS	14		Rejected!	
GOLDRATH_ANTIGEN_RESPONSE	367	362		
GOLDRATH_HOMEOSTATIC_PROLIFERATION	150	143		
GOLDRATH_IMMUNE_MEMORY	66	65		
GOLUB_ALL_VS_AML_DN	23	23		
GOLUB_ALL_VS_AML_UP	24	24		
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	63	62		
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	207	196		
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	68	66		
GOUYER_TATI_TARGETS_DN	17	16		
GOUYER_TATI_TARGETS_UP	10		Rejected!	
GOUYER_TUMOR_INVASIVENESS	9		Rejected!	
GOZGIT_ESR1_TARGETS_DN	785		Rejected!	
GOZGIT_ESR1_TARGETS_UP	149	137		
GRABARCZYK_BCL11B_TARGETS_DN	61	60		
GRABARCZYK_BCL11B_TARGETS_UP	81	81		
GRADE_COLON_AND_RECTAL_CANCER_DN	102	95		
GRADE_COLON_AND_RECTAL_CANCER_UP	290	284		
GRADE_COLON_VS_RECTAL_CANCER_DN	56	53		
GRADE_COLON_VS_RECTAL_CANCER_UP	38	38		
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN	1776		Rejected!	
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	1151		Rejected!	
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN	238	225		
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	567		Rejected!	
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	776		Rejected!	
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	611		Rejected!	
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	86	81		
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	218	206		
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN	10		Rejected!	
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	13		Rejected!	
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	94	92		
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	185	183		
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	12		Rejected!	
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	24	24		
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN	12		Rejected!	
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	59	57		
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	46	45		
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	94	93		
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	89	89		
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	64	64		
GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3	14		Rejected!	
GRANDVAUX_IRF3_TARGETS_DN	18		Rejected!	
GRANDVAUX_IRF3_TARGETS_UP	13		Rejected!	
GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	14		Rejected!	
GRATIAS_RETINOBLASTOMA_16Q24	18	18		
GREENBAUM_E2A_TARGETS_DN	18	18		
GREENBAUM_E2A_TARGETS_UP	33	33		
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	145	136		
GRESHOCK_CANCER_COPY_NUMBER_UP	323	303		
GROSS_ELK3_TARGETS_DN	33	32		
GROSS_ELK3_TARGETS_UP	27	26		
GROSS_HIF1A_TARGETS_DN	26	23		
GROSS_HIF1A_TARGETS_UP	7		Rejected!	
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	104	103		
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	142	137		
GROSS_HYPOXIA_VIA_ELK3_DN	155	150		
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	44	43		
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	34	34		
GROSS_HYPOXIA_VIA_ELK3_UP	210	207		
GROSS_HYPOXIA_VIA_HIF1A_DN	110	103		
GROSS_HYPOXIA_VIA_HIF1A_ONLY	8		Rejected!	
GROSS_HYPOXIA_VIA_HIF1A_UP	78	77		
GRUETZMANN_PANCREATIC_CANCER_DN	200	179		
GRUETZMANN_PANCREATIC_CANCER_UP	359	351		
GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	1009		Rejected!	
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN	438	428		
GRYDER_PAX3FOXO1_TOP_ENHANCERS	441	433		
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	26	26		
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	22	20		
GUILLAUMOND_KLF10_TARGETS_DN	30	29		
GUILLAUMOND_KLF10_TARGETS_UP	50	43		
GUO_HEX_TARGETS_DN	66	66		
GUO_HEX_TARGETS_UP	78	75		
GUO_TARGETS_OF_IRS1_AND_IRS2	96	93		
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	56	56		
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	12		Rejected!	
GUTIERREZ_MULTIPLE_MYELOMA_UP	36	36		
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN	9		Rejected!	
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP	10		Rejected!	
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2	13		Rejected!	
GU_PDEF_TARGETS_DN	40	29		
GU_PDEF_TARGETS_UP	71	65		
GYORFFY_DOXORUBICIN_RESISTANCE	39	35		
GYORFFY_MITOXANTRONE_RESISTANCE	35	32		
HADDAD_B_LYMPHOCYTE_PROGENITOR	290	280		
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	64	64		
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	81	80		
HAEGERSTRAND_RESPONSE_TO_IMATINIB	9		Rejected!	
HAHTOLA_CTCL_CUTANEOUS	26	25		
HAHTOLA_CTCL_PATHOGENESIS	15	15		
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	115	112		
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	63	62		
HAHTOLA_MYCOSIS_FUNGOIDES_DN	17	16		
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	27	27		
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	177	175		
HAHTOLA_MYCOSIS_FUNGOIDES_UP	18	18		
HAHTOLA_SEZARY_SYNDROM_DN	43	43		
HAHTOLA_SEZARY_SYNDROM_UP	99	99		
HALMOS_CEBPA_TARGETS_DN	45	39		
HALMOS_CEBPA_TARGETS_UP	49	44		
HAMAI_APOPTOSIS_VIA_TRAIL_DN	203	187		
HAMAI_APOPTOSIS_VIA_TRAIL_UP	656		Rejected!	
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	48	41		
HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	36	32		
HANSON_HRAS_SIGNALING_VIA_NFKB	24	22		
HAN_JNK_SINGALING_DN	40	37		
HAN_JNK_SINGALING_UP	35	32		
HAN_SATB1_TARGETS_DN	388	377		
HAN_SATB1_TARGETS_UP	425	415		
HARRIS_BRAIN_CANCER_PROGENITORS	43	40		
HARRIS_HYPOXIA	81	76		
HASEGAWA_TUMORIGENESIS_BY_RET_C634R	8		Rejected!	
HASINA_NOL7_TARGETS_DN	13		Rejected!	
HASINA_NOL7_TARGETS_UP	13		Rejected!	
HASLINGER_B_CLL_WITH_11Q23_DELETION	23	23		
HASLINGER_B_CLL_WITH_13Q14_DELETION	24	24		
HASLINGER_B_CLL_WITH_17P13_DELETION	22	22		
HASLINGER_B_CLL_WITH_6Q21_DELETION	22	22		
HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	23	22		
HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	18	18		
HATADA_METHYLATED_IN_LUNG_CANCER_DN	36	30		
HATADA_METHYLATED_IN_LUNG_CANCER_UP	377	332		
HEBERT_MATRISOME_TNBC_BONE_BRAIN_LIVER_LUNG_METASTASTASES	13		Rejected!	
HEBERT_MATRISOME_TNBC_BONE_BRAIN_LUNG_LIVER_METASTASTASES_TUMOR_CELL_DERIVED	7		Rejected!	
HEBERT_MATRISOME_TNBC_BONE_METASTASIS	11		Rejected!	
HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED	5		Rejected!	
HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS	26	26		
HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS_TUMOR_CELL_DERIVED	12		Rejected!	
HEBERT_MATRISOME_TNBC_LIVER_METASTASIS	14		Rejected!	
HEBERT_MATRISOME_TNBC_LUNG_METASTASIS	23	22		
HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED	6		Rejected!	
HECKER_IFNB1_TARGETS	95	92		
HEDENFALK_BREAST_CANCER_BRACX_DN	20	20		
HEDENFALK_BREAST_CANCER_BRACX_UP	19		Rejected!	
HEDVAT_ELF4_TARGETS_UP	12		Rejected!	
HEIDENBLAD_AMPLICON_12P11_12_DN	25	25		
HEIDENBLAD_AMPLICON_12P11_12_UP	36	35		
HEIDENBLAD_AMPLICON_8Q24_DN	39	38		
HEIDENBLAD_AMPLICON_8Q24_UP	41	40		
HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER	7		Rejected!	
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	57	56		
HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER	13		Rejected!	
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	77	75		
HELLER_HDAC_TARGETS_DN	293	288		
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	282	279		
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	461	434		
HELLER_HDAC_TARGETS_UP	317	313		
HELLER_SILENCED_BY_METHYLATION_DN	107	105		
HELLER_SILENCED_BY_METHYLATION_UP	283	260		
HENDRICKS_SMARCA4_TARGETS_DN	49	43		
HENDRICKS_SMARCA4_TARGETS_UP	54	50		
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN	22	22		
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP	71	67		
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN	6		Rejected!	
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP	23	18		
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	37	34		
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP	35	29		
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN	18	18		
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	61	56		
HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3	8		Rejected!	
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	84	82		
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	69	67		
HE_PTEN_TARGETS_DN	7		Rejected!	
HE_PTEN_TARGETS_UP	18	17		
HILLION_HMGA1B_TARGETS	86	75		
HILLION_HMGA1_TARGETS	84	69		
HINATA_NFKB_TARGETS_FIBROBLAST_UP	81	79		
HINATA_NFKB_TARGETS_KERATINOCYTE_DN	23	22		
HINATA_NFKB_TARGETS_KERATINOCYTE_UP	84	81		
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	102	101		
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP	242	235		
HOEBEKE_LYMPHOID_STEM_CELL_DN	88	83		
HOEBEKE_LYMPHOID_STEM_CELL_UP	97	97		
HOEGERKORP_CD44_TARGETS_DIRECT_DN	14		Rejected!	
HOEGERKORP_CD44_TARGETS_DIRECT_UP	26	26		
HOEGERKORP_CD44_TARGETS_TEMPORAL_DN	25	21		
HOEGERKORP_CD44_TARGETS_TEMPORAL_UP	12		Rejected!	
HOELZEL_NF1_TARGETS_DN	118	112		
HOELZEL_NF1_TARGETS_UP	141	135		
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN	48	46		
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP	40	38		
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN	69	66		
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	153	152		
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN	75	74		
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP	29	28		
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	38	34		
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP	66	63		
HOFFMAN_CLOCK_TARGETS_DN	10		Rejected!	
HOFFMAN_CLOCK_TARGETS_UP	10		Rejected!	
HOFMANN_CELL_LYMPHOMA_DN	40	38		
HOFMANN_CELL_LYMPHOMA_UP	48	45		
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN	20	20		
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP	10		Rejected!	
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	29	24		
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	21	21		
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN	23	21		
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP	23	20		
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN	26	25		
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP	23	18		
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN	15		Rejected!	
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	28	18		
HOLLEMAN_DAUNORUBICIN_ALL_DN	8		Rejected!	
HOLLEMAN_DAUNORUBICIN_ALL_UP	7		Rejected!	
HOLLEMAN_DAUNORUBICIN_B_ALL_DN	12		Rejected!	
HOLLEMAN_DAUNORUBICIN_B_ALL_UP	10		Rejected!	
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN	11		Rejected!	
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	20	20		
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN	12		Rejected!	
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP	22	22		
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	20		Rejected!	
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP	27	27		
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN	16		Rejected!	
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP	39	39		
HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR	17	16		
HOLLERN_EMT_BREAST_TUMOR_DN	123	114		
HOLLERN_EMT_BREAST_TUMOR_UP	140	134		
HOLLERN_MICROACINAR_BREAST_TUMOR_DN	15		Rejected!	
HOLLERN_MICROACINAR_BREAST_TUMOR_UP	46	44		
HOLLERN_PAPILLARY_BREAST_TUMOR	19		Rejected!	
HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN	30	29		
HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP	11		Rejected!	
HOLLERN_SQUAMOUS_BREAST_TUMOR	173	119		
HOLLMANN_APOPTOSIS_VIA_CD40_DN	267	261		
HOLLMANN_APOPTOSIS_VIA_CD40_UP	203	198		
HONMA_DOCETAXEL_RESISTANCE	35	31		
HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	17	17		
HOOI_ST7_TARGETS_DN	117	115		
HOOI_ST7_TARGETS_UP	93	89		
HOQUE_METHYLATED_IN_CANCER	56	50		
HORIUCHI_WTAP_TARGETS_DN	319	310		
HORIUCHI_WTAP_TARGETS_UP	308	303		
HORTON_SREBF_TARGETS	24	24		
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	70	65		
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	62	58		
HOSHIDA_LIVER_CANCER_SUBCLASS_S1	235	233		
HOSHIDA_LIVER_CANCER_SUBCLASS_S2	115	104		
HOSHIDA_LIVER_CANCER_SUBCLASS_S3	266	248		
HOSHIDA_LIVER_CANCER_SURVIVAL_DN	113	103		
HOSHIDA_LIVER_CANCER_SURVIVAL_UP	73	70		
HOUNKPE_HOUSEKEEPING_GENES	1129		Rejected!	
HOUSTIS_ROS	36	33		
HOWLIN_CITED1_TARGETS_1_DN	39	38		
HOWLIN_CITED1_TARGETS_1_UP	36	33		
HOWLIN_CITED1_TARGETS_2_DN	18	16		
HOWLIN_CITED1_TARGETS_2_UP	20	17		
HOWLIN_PUBERTAL_MAMMARY_GLAND	67	56		
HO_LIVER_CANCER_VASCULAR_INVASION	13		Rejected!	
HSIAO_HOUSEKEEPING_GENES	397	332		
HSIAO_LIVER_SPECIFIC_GENES	249	212		
HUANG_DASATINIB_RESISTANCE_DN	70	66		
HUANG_DASATINIB_SENSITIVITY_UP	80	78		
HUANG_FOXA2_TARGETS_DN	38	36		
HUANG_FOXA2_TARGETS_UP	47	46		
HUANG_GATA2_TARGETS_DN	74	72		
HUANG_GATA2_TARGETS_UP	152	149		
HUI_MAPK14_TARGETS_UP	19	19		
HUMMEL_BURKITTS_LYMPHOMA_DN	15	15		
HUMMEL_BURKITTS_LYMPHOMA_UP	43	43		
HUMMERICH_BENIGN_SKIN_TUMOR_DN	20	17		
HUMMERICH_BENIGN_SKIN_TUMOR_UP	16		Rejected!	
HUMMERICH_MALIGNANT_SKIN_TUMOR_DN	20	18		
HUMMERICH_MALIGNANT_SKIN_TUMOR_UP	19	15		
HUMMERICH_SKIN_CANCER_PROGRESSION_DN	103	99		
HUMMERICH_SKIN_CANCER_PROGRESSION_UP	88	81		
HUNSBERGER_EXERCISE_REGULATED_GENES	31	28		
HUPER_BREAST_BASAL_VS_LUMINAL_DN	58	55		
HUPER_BREAST_BASAL_VS_LUMINAL_UP	53	41		
HUTTMANN_B_CLL_POOR_SURVIVAL_DN	59	59		
HUTTMANN_B_CLL_POOR_SURVIVAL_UP	285	275		
HU_ANGIOGENESIS_DN	37	36		
HU_ANGIOGENESIS_UP	21	21		
HU_GENOTOXIC_DAMAGE_24HR	36	34		
HU_GENOTOXIC_DAMAGE_4HR	36	36		
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR	51	49		
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR	38	36		
HWANG_PROSTATE_CANCER_MARKERS	28	26		
IBRAHIM_NRF1_DOWN	167	162		
IBRAHIM_NRF1_UP	419	416		
IBRAHIM_NRF2_DOWN	168	164		
IBRAHIM_NRF2_UP	533		Rejected!	
IBRAHIM_NRF3_DOWN	15	15		
IBRAHIM_NRF3_UP	7		Rejected!	
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN	56	49		
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	140	133		
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN	45	40		
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	114	105		
IGARASHI_ATF4_TARGETS_DN	98	95		
IGARASHI_ATF4_TARGETS_UP	5		Rejected!	
IGLESIAS_E2F_TARGETS_DN	14		Rejected!	
IGLESIAS_E2F_TARGETS_UP	144	141		
IIZUKA_LIVER_CANCER_EARLY_RECURRENCE	11		Rejected!	
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	25	25		
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP	12		Rejected!	
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN	9		Rejected!	
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	27	26		
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	17	16		
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15		Rejected!	
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN	10		Rejected!	
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	20	19		
IKEDA_MIR133_TARGETS_DN	6		Rejected!	
IKEDA_MIR133_TARGETS_UP	44	44		
IKEDA_MIR1_TARGETS_DN	7		Rejected!	
IKEDA_MIR1_TARGETS_UP	54	54		
IKEDA_MIR30_TARGETS_DN	25	24		
IKEDA_MIR30_TARGETS_UP	116	115		
IM_SREBF1A_TARGETS	5		Rejected!	
INAMURA_LUNG_CANCER_SCC_DN	13		Rejected!	
INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP	14		Rejected!	
INAMURA_LUNG_CANCER_SCC_UP	13		Rejected!	
INGA_TP53_TARGETS	16	16		
INGRAM_SHH_TARGETS_DN	63	62		
INGRAM_SHH_TARGETS_UP	125	114		
IRITANI_MAD1_TARGETS_DN	46	41		
IRITANI_MAD1_TARGETS_UP	14		Rejected!	
ISHIDA_E2F_TARGETS	53	53		
ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS	6		Rejected!	
ISHIKAWA_STING_SIGNALING	10		Rejected!	
ISSAEVA_MLL2_TARGETS	61	58		
ITO_PTTG1_TARGETS_DN	9		Rejected!	
ITO_PTTG1_TARGETS_UP	12		Rejected!	
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	451	432		
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	135	129		
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR	511	494		
IVANOVA_HEMATOPOIESIS_MATURE_CELL	296	291		
IVANOVA_HEMATOPOIESIS_STEM_CELL	191	181		
IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	563		Rejected!	
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM	217	199		
IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	22	21		
IVANOVSKA_MIR106B_TARGETS	89	89		
IVANOV_MUTATED_IN_COLON_CANCER	13		Rejected!	
IWANAGA_CARCINOGENESIS_BY_KRAS_DN	123	114		
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	355	329		
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP	190	174		
IWANAGA_CARCINOGENESIS_BY_KRAS_UP	173	164		
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	24	24		
IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM	6		Rejected!	
IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS	10		Rejected!	
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	107	99		
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	128	124		
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	235	234		
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP	323	319		
JACKSON_DNMT1_TARGETS_DN	21	19		
JACKSON_DNMT1_TARGETS_UP	83	82		
JAEGER_METASTASIS_DN	259	217		
JAEGER_METASTASIS_UP	46	42		
JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	40	40		
JAIN_NFKB_SIGNALING	75	75		
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	42	40		
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	49	48		
JAZAG_TGFB1_SIGNALING_DN	35	33		
JAZAG_TGFB1_SIGNALING_UP	106	99		
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	65	62		
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	107	94		
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	62	59		
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	67	63		
JEON_SMAD6_TARGETS_DN	19	18		
JEON_SMAD6_TARGETS_UP	24	24		
JEPSEN_SMRT_TARGETS	33	32		
JIANG_AGING_CEREBRAL_CORTEX_DN	49	48		
JIANG_AGING_CEREBRAL_CORTEX_UP	34	30		
JIANG_AGING_HYPOTHALAMUS_DN	35	35		
JIANG_AGING_HYPOTHALAMUS_UP	49	45		
JIANG_CORE_DUPLICON_GENES	13		Rejected!	
JIANG_HYPOXIA_CANCER	58	55		
JIANG_HYPOXIA_NORMAL	200	197		
JIANG_HYPOXIA_VIA_VHL	19	17		
JIANG_TIP30_TARGETS_DN	24	24		
JIANG_TIP30_TARGETS_UP	46	44		
JIANG_VHL_TARGETS	88	83		
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN	387	367		
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP	382	367		
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN	300	288		
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP	170	164		
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN	289	272		
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP	378	363		
JISON_SICKLE_CELL_DISEASE_DN	186	157		
JISON_SICKLE_CELL_DISEASE_UP	182	182		
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN	17		Rejected!	
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP	12		Rejected!	
JI_METASTASIS_REPRESSED_BY_STK11	26	25		
JI_RESPONSE_TO_FSH_DN	53	52		
JI_RESPONSE_TO_FSH_UP	68	68		
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN	43	42		
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP	7		Rejected!	
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN	22	22		
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	57	55		
JOHNSTONE_PARVB_TARGETS_1_DN	64	63		
JOHNSTONE_PARVB_TARGETS_1_UP	7		Rejected!	
JOHNSTONE_PARVB_TARGETS_2_DN	344	339		
JOHNSTONE_PARVB_TARGETS_2_UP	144	142		
JOHNSTONE_PARVB_TARGETS_3_DN	875		Rejected!	
JOHNSTONE_PARVB_TARGETS_3_UP	433	429		
JONES_TCOF1_TARGETS	5		Rejected!	
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN	60	58		
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP	31	31		
JU_AGING_TERC_TARGETS_UP	7		Rejected!	
KAAB_FAILED_HEART_ATRIUM_DN	147	146		
KAAB_FAILED_HEART_ATRIUM_UP	36	30		
KAAB_FAILED_HEART_VENTRICLE_DN	44	41		
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	261	252		
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	256	241		
KALMA_E2F1_TARGETS	11		Rejected!	
KAMIKUBO_MYELOID_CEBPA_NETWORK	30	29		
KAMIKUBO_MYELOID_MN1_NETWORK	19	19		
KAMMINGA_EZH2_TARGETS	41	41		
KAMMINGA_SENESCENCE	40	39		
KANG_AR_TARGETS_DN	18		Rejected!	
KANG_AR_TARGETS_UP	17	15		
KANG_CISPLATIN_RESISTANCE_DN	8		Rejected!	
KANG_CISPLATIN_RESISTANCE_UP	21	21		
KANG_DOXORUBICIN_RESISTANCE_DN	19	19		
KANG_DOXORUBICIN_RESISTANCE_UP	54	54		
KANG_FLUOROURACIL_RESISTANCE_DN	16	16		
KANG_FLUOROURACIL_RESISTANCE_UP	22	22		
KANG_GLIS3_TARGETS	36	26		
KANG_IMMORTALIZED_BY_TERT_DN	101	88		
KANG_IMMORTALIZED_BY_TERT_UP	88	81		
KANNAN_TP53_TARGETS_DN	22	22		
KANNAN_TP53_TARGETS_UP	59	56		
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	123	113		
KAPOSI_LIVER_CANCER_MET_DN	6		Rejected!	
KAPOSI_LIVER_CANCER_MET_UP	18	17		
KARAKAS_TGFB1_SIGNALING	18	16		
KARLSSON_TGFB1_TARGETS_DN	194	193		
KARLSSON_TGFB1_TARGETS_UP	123	119		
KASLER_HDAC7_TARGETS_1_DN	17	17		
KASLER_HDAC7_TARGETS_1_UP	192	187		
KASLER_HDAC7_TARGETS_2_DN	33	32		
KASLER_HDAC7_TARGETS_2_UP	6		Rejected!	
KATSANOU_ELAVL1_TARGETS_DN	147	136		
KATSANOU_ELAVL1_TARGETS_UP	173	162		
KAUFFMANN_DNA_REPAIR_GENES	230	228		
KAUFFMANN_DNA_REPLICATION_GENES	146	145		
KAUFFMANN_MELANOMA_RELAPSE_DN	6		Rejected!	
KAUFFMANN_MELANOMA_RELAPSE_UP	61	61		
KAYO_AGING_MUSCLE_DN	124	114		
KAYO_AGING_MUSCLE_UP	242	216		
KAYO_CALORIE_RESTRICTION_MUSCLE_DN	87	78		
KAYO_CALORIE_RESTRICTION_MUSCLE_UP	94	88		
KENNY_CTNNB1_TARGETS_DN	52	51		
KENNY_CTNNB1_TARGETS_UP	50	49		
KERLEY_RESPONSE_TO_CISPLATIN_DN	5		Rejected!	
KERLEY_RESPONSE_TO_CISPLATIN_UP	45	44		
KESHELAVA_MULTIPLE_DRUG_RESISTANCE	82	80		
KHETCHOUMIAN_TRIM24_TARGETS_DN	8		Rejected!	
KHETCHOUMIAN_TRIM24_TARGETS_UP	46	45		
KIM_ALL_DISORDERS_CALB1_CORR_DN	36	32		
KIM_ALL_DISORDERS_CALB1_CORR_UP	547		Rejected!	
KIM_ALL_DISORDERS_DURATION_CORR_DN	145	140		
KIM_ALL_DISORDERS_DURATION_CORR_UP	9		Rejected!	
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN	33	30		
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP	755		Rejected!	
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	87	67		
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP	680		Rejected!	
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	95	85		
KIM_GERMINAL_CENTER_T_HELPER_DN	12		Rejected!	
KIM_GERMINAL_CENTER_T_HELPER_UP	64	64		
KIM_GLIS2_TARGETS_DN	6		Rejected!	
KIM_GLIS2_TARGETS_UP	86	84		
KIM_HYPOXIA	17	17		
KIM_LIVER_CANCER_POOR_SURVIVAL_DN	43	39		
KIM_LIVER_CANCER_POOR_SURVIVAL_UP	22	22		
KIM_LRRC3B_TARGETS	30	30		
KIM_MYCL1_AMPLIFICATION_TARGETS_DN	20	20		
KIM_MYCL1_AMPLIFICATION_TARGETS_UP	14		Rejected!	
KIM_MYCN_AMPLIFICATION_TARGETS_DN	107	104		
KIM_MYCN_AMPLIFICATION_TARGETS_UP	93	84		
KIM_MYC_AMPLIFICATION_TARGETS_DN	98	94		
KIM_MYC_AMPLIFICATION_TARGETS_UP	202	181		
KIM_PTEN_TARGETS_DN	5		Rejected!	
KIM_PTEN_TARGETS_UP	18	18		
KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	10		Rejected!	
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	136	116		
KIM_TIAL1_TARGETS	31	28		
KIM_WT1_TARGETS_12HR_DN	216	207		
KIM_WT1_TARGETS_12HR_UP	166	160		
KIM_WT1_TARGETS_8HR_DN	126	119		
KIM_WT1_TARGETS_8HR_UP	167	162		
KIM_WT1_TARGETS_DN	472	454		
KIM_WT1_TARGETS_UP	217	210		
KINNEY_DNMT1_METHYLATION_TARGETS	15		Rejected!	
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	337	330		
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	1291		Rejected!	
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	58	58		
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	50	50		
KLEIN_TARGETS_OF_BCR_ABL1_FUSION	46	45		
KOBAYASHI_EGFR_SIGNALING_24HR_DN	253	250		
KOBAYASHI_EGFR_SIGNALING_24HR_UP	102	95		
KOBAYASHI_EGFR_SIGNALING_6HR_DN	18	18		
KOBAYASHI_EGFR_SIGNALING_6HR_UP	7		Rejected!	
KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	19	19		
KOHN_EMT_EPITHELIAL	22	21		
KOHN_EMT_MESENCHYMAL	15		Rejected!	
KOHOUTEK_CCNT1_TARGETS	52	48		
KOHOUTEK_CCNT2_TARGETS	58	45		
KOINUMA_COLON_CANCER_MSI_DN	8		Rejected!	
KOINUMA_COLON_CANCER_MSI_UP	16	16		
KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	842		Rejected!	
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	61	61		
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	130	129		
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	72	72		
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	118	117		
KOMMAGANI_TP63_GAMMA_TARGETS	9		Rejected!	
KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	26	24		
KONDO_COLON_CANCER_HCP_WITH_H3K27ME3	6		Rejected!	
KONDO_EZH2_TARGETS	229	210		
KONDO_HYPOXIA	8		Rejected!	
KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	97	84		
KONDO_PROSTATE_CANCER_WITH_H3K27ME3	194	132		
KONG_E2F1_TARGETS	11		Rejected!	
KONG_E2F3_TARGETS	100	97		
KORKOLA_CHORIOCARCINOMA	7		Rejected!	
KORKOLA_CHORIOCARCINOMA_DN	11		Rejected!	
KORKOLA_CHORIOCARCINOMA_UP	6		Rejected!	
KORKOLA_CORRELATED_WITH_POU5F1	32	30		
KORKOLA_EMBRYONAL_CARCINOMA	11		Rejected!	
KORKOLA_EMBRYONAL_CARCINOMA_DN	13		Rejected!	
KORKOLA_EMBRYONAL_CARCINOMA_UP	42	41		
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	25	22		
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	24	20		
KORKOLA_SEMINOMA_DN	13		Rejected!	
KORKOLA_SEMINOMA_UP	44	43		
KORKOLA_TERATOMA	42	39		
KORKOLA_TERATOMA_UP	17	17		
KORKOLA_YOLK_SAC_TUMOR	65	54		
KORKOLA_YOLK_SAC_TUMOR_UP	20	20		
KOYAMA_SEMA3B_TARGETS_DN	364	351		
KOYAMA_SEMA3B_TARGETS_UP	267	252		
KRASNOSELSKAYA_ILF3_TARGETS_DN	46	43		
KRASNOSELSKAYA_ILF3_TARGETS_UP	40	36		
KREPPEL_CD99_TARGETS_DN	7		Rejected!	
KRIEG_HYPOXIA_NOT_VIA_KDM3A	746		Rejected!	
KRIEG_HYPOXIA_VIA_KDM3A	53	53		
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	200	194		
KRIGE_AMINO_ACID_DEPRIVATION	29	28		
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	1041		Rejected!	
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	779		Rejected!	
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	947		Rejected!	
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	941		Rejected!	
KRISHNAN_FURIN_TARGETS_DN	9		Rejected!	
KRISHNAN_FURIN_TARGETS_UP	10		Rejected!	
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN	10		Rejected!	
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP	9		Rejected!	
KUMAR_AUTOPHAGY_NETWORK	72	64		
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES	274	245		
KUMAR_TARGETS_OF_MLL_AF9_FUSION	408	397		
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN	46	43		
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	82	74		
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN	6		Rejected!	
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	12		Rejected!	
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	45	43		
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD	21	20		
KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	35	29		
KUWANO_RNA_STABILIZED_BY_NO	7		Rejected!	
KYNG_DNA_DAMAGE_BY_4NQO	36	35		
KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION	15	15		
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	60	57		
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	77	73		
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	77	73		
KYNG_DNA_DAMAGE_BY_UV	54	54		
KYNG_DNA_DAMAGE_DN	182	177		
KYNG_DNA_DAMAGE_UP	205	195		
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN	17	16		
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD	12		Rejected!	
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	37	36		
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	29	29		
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	31	29		
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	23	22		
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS	12		Rejected!	
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP	53	51		
KYNG_NORMAL_AGING_DN	18	18		
KYNG_NORMAL_AGING_UP	15	15		
KYNG_RESPONSE_TO_H2O2	66	61		
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6	17		Rejected!	
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN	45	41		
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP	36	35		
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	186	178		
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP	77	75		
KYNG_WERNER_SYNDROM_DN	19	19		
KYNG_WERNER_SYNDROM_UP	14		Rejected!	
LAIHO_COLORECTAL_CANCER_SERRATED_DN	85	83		
LAIHO_COLORECTAL_CANCER_SERRATED_UP	115	113		
LAMB_CCND1_TARGETS	20	18		
LANDEMAINE_LUNG_METASTASIS	21	21		
LANDIS_BREAST_CANCER_PROGRESSION_DN	72	68		
LANDIS_BREAST_CANCER_PROGRESSION_UP	46	44		
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	57	56		
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP	19	18		
LANDIS_ERBB2_BREAST_TUMORS_324_DN	151	141		
LANDIS_ERBB2_BREAST_TUMORS_324_UP	150	147		
LANDIS_ERBB2_BREAST_TUMORS_65_DN	39	36		
LANDIS_ERBB2_BREAST_TUMORS_65_UP	22	22		
LANG_MYB_FAMILY_TARGETS	29	29		
LASTOWSKA_COAMPLIFIED_WITH_MYCN	43	40		
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	807		Rejected!	
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	186	175		
LAU_APOPTOSIS_CDKN2A_DN	5		Rejected!	
LAU_APOPTOSIS_CDKN2A_UP	55	55		
LA_MEN1_TARGETS	25	23		
LEE_AGING_CEREBELLUM_DN	73	65		
LEE_AGING_CEREBELLUM_UP	84	83		
LEE_AGING_MUSCLE_DN	40	39		
LEE_AGING_MUSCLE_UP	38	36		
LEE_AGING_NEOCORTEX_DN	68	62		
LEE_AGING_NEOCORTEX_UP	78	74		
LEE_BMP2_TARGETS_DN	899		Rejected!	
LEE_BMP2_TARGETS_UP	778		Rejected!	
LEE_CALORIE_RESTRICTION_MUSCLE_DN	48	45		
LEE_CALORIE_RESTRICTION_MUSCLE_UP	39	36		
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN	69	61		
LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	68	65		
LEE_DIFFERENTIATING_T_LYMPHOCYTE	201	199		
LEE_DOUBLE_POLAR_THYMOCYTE	28	28		
LEE_EARLY_T_LYMPHOCYTE_DN	58	58		
LEE_EARLY_T_LYMPHOCYTE_UP	111	111		
LEE_INTRATHYMIC_T_PROGENITOR	20	20		
LEE_LIVER_CANCER_ACOX1_DN	65	57		
LEE_LIVER_CANCER_ACOX1_UP	65	59		
LEE_LIVER_CANCER_CIPROFIBRATE_DN	66	56		
LEE_LIVER_CANCER_CIPROFIBRATE_UP	60	55		
LEE_LIVER_CANCER_DENA_DN	74	67		
LEE_LIVER_CANCER_DENA_UP	60	52		
LEE_LIVER_CANCER_E2F1_DN	64	57		
LEE_LIVER_CANCER_E2F1_UP	63	57		
LEE_LIVER_CANCER_HEPATOBLAST	16		Rejected!	
LEE_LIVER_CANCER_MYC_DN	63	57		
LEE_LIVER_CANCER_MYC_E2F1_DN	64	60		
LEE_LIVER_CANCER_MYC_E2F1_UP	56	51		
LEE_LIVER_CANCER_MYC_TGFA_DN	65	61		
LEE_LIVER_CANCER_MYC_TGFA_UP	61	53		
LEE_LIVER_CANCER_MYC_UP	54	44		
LEE_LIVER_CANCER_SURVIVAL_DN	180	161		
LEE_LIVER_CANCER_SURVIVAL_UP	187	168		
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	45	42		
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	74	71		
LEE_METASTASIS_AND_RNA_PROCESSING_UP	16	16		
LEE_NAIVE_T_LYMPHOCYTE	20	19		
LEE_NEURAL_CREST_STEM_CELL_DN	122	115		
LEE_NEURAL_CREST_STEM_CELL_UP	147	129		
LEE_RECENT_THYMIC_EMIGRANT	239	235		
LEE_SP4_THYMOCYTE	15		Rejected!	
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	87	82		
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP	56	51		
LEIN_ASTROCYTE_MARKERS	43	39		
LEIN_CEREBELLUM_MARKERS	85	72		
LEIN_CHOROID_PLEXUS_MARKERS	105	93		
LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES	18	17		
LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES	37	37		
LEIN_MEDULLA_MARKERS	86	81		
LEIN_MIDBRAIN_MARKERS	83	72		
LEIN_NEURON_MARKERS	69	65		
LEIN_OLIGODENDROCYTE_MARKERS	76	73		
LEIN_PONS_MARKERS	92	84		
LEI_HOXC8_TARGETS_DN	17	15		
LEI_HOXC8_TARGETS_UP	11		Rejected!	
LEI_MYB_TARGETS	323	304		
LENAOUR_DENDRITIC_CELL_MATURATION_DN	130	130		
LENAOUR_DENDRITIC_CELL_MATURATION_UP	116	113		
LEONARD_HYPOXIA	41	39		
LE_EGR2_TARGETS_DN	107	102		
LE_EGR2_TARGETS_UP	109	104		
LE_NEURONAL_DIFFERENTIATION_DN	19	18		
LE_NEURONAL_DIFFERENTIATION_UP	18	17		
LE_SKI_TARGETS_DN	7		Rejected!	
LE_SKI_TARGETS_UP	17		Rejected!	
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN	43	42		
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	40	39		
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL	16	16		
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	33	32		
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP	39	38		
LIANG_SILENCED_BY_METHYLATION_2	58	51		
LIANG_SILENCED_BY_METHYLATION_DN	11		Rejected!	
LIANG_SILENCED_BY_METHYLATION_UP	33	29		
LIAN_LIPA_TARGETS_3M	65	61		
LIAN_LIPA_TARGETS_6M	81	76		
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	25	24		
LIAO_HAVE_SOX4_BINDING_SITES	41	39		
LIAO_METASTASIS	540		Rejected!	
LIEN_BREAST_CARCINOMA_METAPLASTIC	33	30		
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	115	96		
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	83	80		
LIM_MAMMARY_LUMINAL_MATURE_DN	94	90		
LIM_MAMMARY_LUMINAL_MATURE_UP	113	107		
LIM_MAMMARY_LUMINAL_PROGENITOR_DN	14		Rejected!	
LIM_MAMMARY_LUMINAL_PROGENITOR_UP	58	48		
LIM_MAMMARY_STEM_CELL_DN	416	403		
LIM_MAMMARY_STEM_CELL_UP	480	453		
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	378	368		
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	120	112		
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	141	139		
LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP	8		Rejected!	
LINDGREN_BLADDER_CANCER_CLUSTER_2B	389	374		
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	226	215		
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	327	321		
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	49	48		
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	116	114		
LINDSTEDT_DENDRITIC_CELL_MATURATION_A	61	60		
LINDSTEDT_DENDRITIC_CELL_MATURATION_B	49	49		
LINDSTEDT_DENDRITIC_CELL_MATURATION_C	63	62		
LINDSTEDT_DENDRITIC_CELL_MATURATION_D	63	62		
LINDVALL_IMMORTALIZED_BY_TERT_DN	73	69		
LINDVALL_IMMORTALIZED_BY_TERT_UP	68	62		
LINSLEY_MIR16_TARGETS	206	205		
LIN_APC_TARGETS	71	70		
LIN_MELANOMA_COPY_NUMBER_DN	41	40		
LIN_MELANOMA_COPY_NUMBER_UP	72	64		
LIN_NPAS4_TARGETS_DN	71	66		
LIN_NPAS4_TARGETS_UP	171	169		
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	107	90		
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK	19	16		
LIU_BREAST_CANCER	32	29		
LIU_CDX2_TARGETS_DN	8		Rejected!	
LIU_CDX2_TARGETS_UP	35	26		
LIU_CMYB_TARGETS_DN	6		Rejected!	
LIU_CMYB_TARGETS_UP	164	155		
LIU_COMMON_CANCER_GENES	63	60		
LIU_IL13_MEMORY_MODEL_DN	5		Rejected!	
LIU_IL13_MEMORY_MODEL_UP	17	16		
LIU_IL13_PRIMING_MODEL	15		Rejected!	
LIU_LIVER_CANCER	35	32		
LIU_NASOPHARYNGEAL_CARCINOMA	72	67		
LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN	34	34		
LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_DN	1716		Rejected!	
LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP	250	231		
LIU_PROSTATE_CANCER_DN	493	458		
LIU_PROSTATE_CANCER_UP	99	95		
LIU_SMARCA4_TARGETS	50	46		
LIU_SOX4_TARGETS_DN	310	307		
LIU_SOX4_TARGETS_UP	139	137		
LIU_TARGETS_OF_VMYB_VS_CMYB_DN	44	44		
LIU_TARGETS_OF_VMYB_VS_CMYB_UP	16		Rejected!	
LIU_TOPBP1_TARGETS	14		Rejected!	
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	17	15		
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	89	82		
LIU_VMYB_TARGETS_UP	125	121		
LI_ADIPOGENESIS_BY_ACTIVATED_PPARG	18	17		
LI_AMPLIFIED_IN_LUNG_CANCER	183	152		
LI_CISPLATIN_RESISTANCE_DN	33	30		
LI_CISPLATIN_RESISTANCE_UP	26	25		
LI_CYTIDINE_ANALOGS_CYCTOTOXICITY	15	15		
LI_CYTIDINE_ANALOG_PATHWAY	17	16		
LI_DCP2_BOUND_MRNA	89	84		
LI_INDUCED_T_TO_NATURAL_KILLER_DN	137	134		
LI_INDUCED_T_TO_NATURAL_KILLER_UP	317	313		
LI_LUNG_CANCER	41	38		
LI_PROSTATE_CANCER_EPIGENETIC	32	30		
LI_WILMS_TUMOR	27	22		
LI_WILMS_TUMOR_ANAPLASTIC_DN	5		Rejected!	
LI_WILMS_TUMOR_ANAPLASTIC_UP	17	17		
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	164	162		
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	183	176		
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN	48	46		
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP	27	26		
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	216	208		
LOPES_METHYLATED_IN_COLON_CANCER_DN	28	27		
LOPES_METHYLATED_IN_COLON_CANCER_UP	28	24		
LOPEZ_EPITHELIOID_MESOTHELIOMA	17	15		
LOPEZ_MBD_TARGETS	954		Rejected!	
LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED	17	16		
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN	7		Rejected!	
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP	14		Rejected!	
LOPEZ_MESOTHELIOMA_SURVIVAL_DN	12		Rejected!	
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	15		Rejected!	
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP	8		Rejected!	
LOPEZ_MESOTHELIOMA_SURVIVAL_UP	12		Rejected!	
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN	7		Rejected!	
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP	14		Rejected!	
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING	35	35		
LUCAS_HNF4A_TARGETS_DN	8		Rejected!	
LUCAS_HNF4A_TARGETS_UP	58	57		
LUDWICZEK_TREATING_IRON_OVERLOAD	7		Rejected!	
LUI_TARGETS_OF_PAX8_PPARG_FUSION	34	28		
LUI_THYROID_CANCER_CLUSTER_1	52	51		
LUI_THYROID_CANCER_CLUSTER_2	43	43		
LUI_THYROID_CANCER_CLUSTER_3	28	21		
LUI_THYROID_CANCER_CLUSTER_4	21	20		
LUI_THYROID_CANCER_CLUSTER_5	16		Rejected!	
LUI_THYROID_CANCER_PAX8_PPARG_DN	46	38		
LUI_THYROID_CANCER_PAX8_PPARG_UP	46	45		
LUND_SILENCED_BY_METHYLATION	16	16		
LU_AGING_BRAIN_DN	153	148		
LU_AGING_BRAIN_UP	263	257		
LU_EZH2_TARGETS_DN	400	392		
LU_EZH2_TARGETS_UP	289	276		
LU_IL4_SIGNALING	91	87		
LU_TUMOR_ANGIOGENESIS_UP	25	25		
LU_TUMOR_ENDOTHELIAL_MARKERS_DN	5		Rejected!	
LU_TUMOR_ENDOTHELIAL_MARKERS_UP	22	19		
LU_TUMOR_VASCULATURE_DN	13		Rejected!	
LU_TUMOR_VASCULATURE_UP	29	25		
LY_AGING_MIDDLE_DN	16	16		
LY_AGING_MIDDLE_UP	14		Rejected!	
LY_AGING_OLD_DN	56	54		
LY_AGING_OLD_UP	7		Rejected!	
LY_AGING_PREMATURE_DN	30	28		
MACAEVA_PBMC_RESPONSE_TO_IR	106	103		
MACLACHLAN_BRCA1_TARGETS_DN	16	15		
MACLACHLAN_BRCA1_TARGETS_UP	21	21		
MADAN_DPPA4_TARGETS	62	50		
MAEKAWA_ATF2_TARGETS	24	22		
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN	28	28		
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP	20	19		
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN	24	22		
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP	41	39		
MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	15		Rejected!	
MAHADEVAN_IMATINIB_RESISTANCE_DN	20	16		
MAHADEVAN_IMATINIB_RESISTANCE_UP	22	18		
MAHAJAN_RESPONSE_TO_IL1A_DN	70	65		
MAHAJAN_RESPONSE_TO_IL1A_UP	77	70		
MAINA_HYPOXIA_VHL_TARGETS_UP	6		Rejected!	
MAINA_VHL_TARGETS_DN	16	15		
MAINA_VHL_TARGETS_UP	10		Rejected!	
MALIK_REPRESSED_BY_ESTROGEN	13		Rejected!	
MALONEY_RESPONSE_TO_17AAG_DN	77	71		
MALONEY_RESPONSE_TO_17AAG_UP	40	39		
MALTA_CURATED_STEMNESS_MARKERS	21	18		
MANALO_HYPOXIA_DN	292	287		
MANALO_HYPOXIA_UP	205	203		
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN	225	224		
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP	179	178		
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN	159	159		
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP	128	126		
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN	208	207		
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP	143	142		
MANN_RESPONSE_TO_AMIFOSTINE_DN	9		Rejected!	
MANN_RESPONSE_TO_AMIFOSTINE_UP	19	19		
MARCHINI_TRABECTEDIN_RESISTANCE_DN	46	45		
MARCHINI_TRABECTEDIN_RESISTANCE_UP	20	20		
MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP	22	21		
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN	42	41		
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP	61	61		
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1	8		Rejected!	
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2	8		Rejected!	
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8	10		Rejected!	
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	16	16		
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	47	46		
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	23	21		
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7	14		Rejected!	
MARKEY_RB1_ACUTE_LOF_DN	233	223		
MARKEY_RB1_ACUTE_LOF_UP	235	232		
MARKEY_RB1_CHRONIC_LOF_DN	120	112		
MARKEY_RB1_CHRONIC_LOF_UP	113	108		
MARKS_ACETYLATED_NON_HISTONE_PROTEINS	12		Rejected!	
MARKS_HDAC_TARGETS_DN	15	15		
MARKS_HDAC_TARGETS_UP	23	23		
MARSHALL_VIRAL_INFECTION_RESPONSE_DN	29	29		
MARSHALL_VIRAL_INFECTION_RESPONSE_UP	9		Rejected!	
MARSON_BOUND_BY_E2F4_UNSTIMULATED	714		Rejected!	
MARSON_BOUND_BY_FOXP3_STIMULATED	1023		Rejected!	
MARSON_BOUND_BY_FOXP3_UNSTIMULATED	1236		Rejected!	
MARSON_FOXP3_CORE_DIRECT_TARGETS	17	17		
MARSON_FOXP3_TARGETS_DN	54	53		
MARSON_FOXP3_TARGETS_STIMULATED_DN	10		Rejected!	
MARSON_FOXP3_TARGETS_STIMULATED_UP	30	29		
MARSON_FOXP3_TARGETS_UP	66	66		
MARTENS_BOUND_BY_PML_RARA_FUSION	456	441		
MARTENS_TRETINOIN_RESPONSE_DN	839		Rejected!	
MARTENS_TRETINOIN_RESPONSE_UP	855		Rejected!	
MARTINELLI_IMMATURE_NEUTROPHIL_DN	13		Rejected!	
MARTINELLI_IMMATURE_NEUTROPHIL_UP	11		Rejected!	
MARTINEZ_RB1_AND_TP53_TARGETS_DN	607		Rejected!	
MARTINEZ_RB1_AND_TP53_TARGETS_UP	622		Rejected!	
MARTINEZ_RB1_TARGETS_DN	568	494		
MARTINEZ_RB1_TARGETS_UP	687		Rejected!	
MARTINEZ_RESPONSE_TO_TRABECTEDIN	50	50		
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	272	267		
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	71	67		
MARTINEZ_TP53_TARGETS_DN	612		Rejected!	
MARTINEZ_TP53_TARGETS_UP	623		Rejected!	
MARTIN_INTERACT_WITH_HDAC	41	40		
MARTIN_NFKB_TARGETS_DN	11		Rejected!	
MARTIN_NFKB_TARGETS_UP	42	39		
MARTIN_VIRAL_GPCR_SIGNALING_DN	52	44		
MARTIN_VIRAL_GPCR_SIGNALING_UP	85	76		
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	518	495		
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP	238	224		
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN	163	144		
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	177	168		
MARZEC_IL2_SIGNALING_DN	36	36		
MARZEC_IL2_SIGNALING_UP	115	115		
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN	20	17		
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP	20	17		
MASSARWEH_RESPONSE_TO_ESTRADIOL	62	60		
MASSARWEH_TAMOXIFEN_RESISTANCE_DN	256	240		
MASSARWEH_TAMOXIFEN_RESISTANCE_UP	582		Rejected!	
MATHEW_FANCONI_ANEMIA_GENES	11		Rejected!	
MATSUDA_NATURAL_KILLER_DIFFERENTIATION	483	466		
MATTHEWS_AP1_TARGETS	17	17		
MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN	18	15		
MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	17	17		
MATTIOLI_MGUS_VS_PCL	127	123		
MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	17		Rejected!	
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	37	36		
MATZUK_CENTRAL_FOR_FEMALE_FERTILITY	29	22		
MATZUK_CUMULUS_EXPANSION	9		Rejected!	
MATZUK_EARLY_ANTRAL_FOLLICLE	13		Rejected!	
MATZUK_EMBRYONIC_GERM_CELL	19	16		
MATZUK_FERTILIZATION	8		Rejected!	
MATZUK_IMPLANTATION_AND_UTERINE	22	21		
MATZUK_LUTEAL_GENES	8		Rejected!	
MATZUK_MALE_REPRODUCTION_SERTOLI	28	25		
MATZUK_MATERNAL_EFFECT	9		Rejected!	
MATZUK_MEIOTIC_AND_DNA_REPAIR	39	37		
MATZUK_OVULATION	15		Rejected!	
MATZUK_POSTIMPLANTATION_AND_POSTPARTUM	14		Rejected!	
MATZUK_PREOVULATORY_FOLLICLE	10		Rejected!	
MATZUK_SPERMATID_DIFFERENTIATION	37	30		
MATZUK_SPERMATOCYTE	72	70		
MATZUK_SPERMATOGONIA	25	22		
MATZUK_SPERMATOZOA	114	99		
MATZUK_STEROIDOGENESIS	7		Rejected!	
MAYBURD_RESPONSE_TO_L663536_DN	56	52		
MAYBURD_RESPONSE_TO_L663536_UP	31	31		
MA_MYELOID_DIFFERENTIATION_DN	42	41		
MA_MYELOID_DIFFERENTIATION_UP	38	37		
MA_RAT_AGING_DN	161	142		
MA_RAT_AGING_UP	107	87		
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN	42	37		
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP	214	194		
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	202	193		
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	270	239		
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	132	127		
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP	123	109		
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	78	73		
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	198	192		
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	62	59		
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	168	162		
MCBRYAN_TERMINAL_END_BUD_DN	6		Rejected!	
MCBRYAN_TERMINAL_END_BUD_UP	12		Rejected!	
MCCABE_BOUND_BY_HOXC6	460	401		
MCCABE_HOXC6_TARGETS_CANCER_DN	20	19		
MCCABE_HOXC6_TARGETS_CANCER_UP	31	29		
MCCABE_HOXC6_TARGETS_DN	21	20		
MCCABE_HOXC6_TARGETS_UP	10		Rejected!	
MCCLUNG_COCAINE_REWARD_5D	75	70		
MCCLUNG_COCAIN_REWARD_4WK	74	67		
MCCLUNG_CREB1_TARGETS_DN	56	52		
MCCLUNG_CREB1_TARGETS_UP	100	93		
MCCLUNG_DELTA_FOSB_TARGETS_2WK	48	46		
MCCLUNG_DELTA_FOSB_TARGETS_8WK	49	47		
MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN	7		Rejected!	
MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP	10		Rejected!	
MCDOWELL_ACUTE_LUNG_INJURY_DN	47	44		
MCDOWELL_ACUTE_LUNG_INJURY_UP	47	43		
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	42	35		
MCGOWAN_RSP6_TARGETS_DN	5		Rejected!	
MCGOWAN_RSP6_TARGETS_UP	20	18		
MCLACHLAN_DENTAL_CARIES_DN	82	76		
MCLACHLAN_DENTAL_CARIES_UP	265	257		
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN	67	64		
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP	26	23		
MEBARKI_HCC_PROGENITOR_FZD8CRD_DN	459	412		
MEBARKI_HCC_PROGENITOR_FZD8CRD_UP	586		Rejected!	
MEBARKI_HCC_PROGENITOR_WNT_DN	92	82		
MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD	70	67		
MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT	31	30		
MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD	22	21		
MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_INDEPENDENT	16		Rejected!	
MEBARKI_HCC_PROGENITOR_WNT_UP	202	183		
MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD	125	114		
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT	90	77		
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD	47	41		
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT	24	22		
MEDINA_SMARCA4_TARGETS	36	34		
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	19	18		
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	12		Rejected!	
MEISSNER_BRAIN_HCP_WITH_H3K27ME3	272	196		
MEISSNER_BRAIN_HCP_WITH_H3K4ME2	18	17		
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	60	53		
MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	1074		Rejected!	
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	40	38		
MEISSNER_BRAIN_ICP_WITH_H3K4ME3	31	28		
MEISSNER_ES_ICP_WITH_H3K4ME3	32	30		
MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	14		Rejected!	
MEISSNER_NPC_HCP_WITH_H3K27ME3	79	52		
MEISSNER_NPC_HCP_WITH_H3K4ME2	493	455		
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3	350	272		
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	143	131		
MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED	544	486		
MEISSNER_NPC_ICP_WITH_H3K4ME3	19	18		
MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED	23	16		
MELLMAN_TUT1_TARGETS_DN	47	45		
MELLMAN_TUT1_TARGETS_UP	20	18		
MENSE_HYPOXIA_UP	100	98		
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	55	49		
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN	6		Rejected!	
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP	7		Rejected!	
MIKI_COEXPRESSED_WITH_CYP19A1	7		Rejected!	
MIKKELSEN_DEDIFFERENTIATED_STATE_DN	7		Rejected!	
MIKKELSEN_DEDIFFERENTIATED_STATE_UP	8		Rejected!	
MIKKELSEN_ES_HCP_WITH_H3K27ME3	41	25		
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED	66	50		
MIKKELSEN_ES_ICP_WITH_H3K27ME3	43	35		
MIKKELSEN_ES_ICP_WITH_H3K4ME3	729		Rejected!	
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	136	106		
MIKKELSEN_ES_LCP_WITH_H3K27ME3	14		Rejected!	
MIKKELSEN_ES_LCP_WITH_H3K4ME3	146	128		
MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3	7		Rejected!	
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	86	65		
MIKKELSEN_IPS_ICP_WITH_H3K27ME3	55	41		
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	124	102		
MIKKELSEN_IPS_LCP_WITH_H3K27ME3	10		Rejected!	
MIKKELSEN_IPS_LCP_WITH_H3K4ME3	175	157		
MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3	5		Rejected!	
MIKKELSEN_IPS_WITH_HCP_H3K27ME3	103	66		
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3	438	338		
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	75	59		
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3	34	28		
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	28	18		
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	162	143		
MIKKELSEN_MEF_HCP_WITH_H3K27ME3	591	448		
MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	238	187		
MIKKELSEN_MEF_ICP_WITH_H3K27ME3	207	165		
MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3	38	31		
MIKKELSEN_MEF_LCP_WITH_H3K27ME3	71	55		
MIKKELSEN_MEF_LCP_WITH_H3K4ME3	128	121		
MIKKELSEN_NPC_HCP_WITH_H3K27ME3	345	251		
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	210	183		
MIKKELSEN_NPC_ICP_WITH_H3K27ME3	12		Rejected!	
MIKKELSEN_NPC_ICP_WITH_H3K4ME3	450	431		
MIKKELSEN_NPC_LCP_WITH_H3K4ME3	60	52		
MIKKELSEN_NPC_WITH_LCP_H3K27ME3	9		Rejected!	
MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY	10		Rejected!	
MIKKELSEN_PLURIPOTENT_STATE_DN	8		Rejected!	
MIKKELSEN_PLURIPOTENT_STATE_UP	11		Rejected!	
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN	10		Rejected!	
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP	10		Rejected!	
MILI_PSEUDOPODIA	48	48		
MILI_PSEUDOPODIA_CHEMOTAXIS_DN	427	419		
MILI_PSEUDOPODIA_CHEMOTAXIS_UP	84	84		
MILI_PSEUDOPODIA_HAPTOTAXIS_DN	671		Rejected!	
MILI_PSEUDOPODIA_HAPTOTAXIS_UP	521		Rejected!	
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN	21	19		
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP	14		Rejected!	
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	24	21		
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	24	22		
MISIAK_ANAPLASTIC_THYROID_CARCINOMA_DN	20	19		
MISIAK_ANAPLASTIC_THYROID_CARCINOMA_UP	45	42		
MISSIAGLIA_REGULATED_BY_METHYLATION_DN	122	121		
MISSIAGLIA_REGULATED_BY_METHYLATION_UP	125	119		
MITSIADES_RESPONSE_TO_APLIDIN_DN	250	245		
MITSIADES_RESPONSE_TO_APLIDIN_UP	445	438		
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	235	220		
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	265	248		
MIZUKAMI_HYPOXIA_DN	6		Rejected!	
MIZUKAMI_HYPOXIA_UP	12		Rejected!	
MIZUSHIMA_AUTOPHAGOSOME_FORMATION	12		Rejected!	
MMS_MOUSE_LYMPH_HIGH_4HRS_UP	36	36		
MODY_HIPPOCAMPUS_NEONATAL	33	30		
MODY_HIPPOCAMPUS_POSTNATAL	56	53		
MODY_HIPPOCAMPUS_PRENATAL	45	31		
MOHANKUMAR_HOXA1_TARGETS_DN	175	151		
MOHANKUMAR_HOXA1_TARGETS_UP	410	399		
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	59	59		
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	68	67		
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN	384	376		
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	407	395		
MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN	11		Rejected!	
MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP	12		Rejected!	
MOOTHA_FFA_OXYDATION	24	24		
MOOTHA_GLUCONEOGENESIS	31	29		
MOOTHA_GLYCOGEN_METABOLISM	21	20		
MOOTHA_GLYCOLYSIS	21	20		
MOOTHA_HUMAN_MITODB_6_2002	432	374		
MOOTHA_MITOCHONDRIA	451	394		
MOOTHA_PGC	421	400		
MOOTHA_PYR	8		Rejected!	
MOOTHA_ROS	7		Rejected!	
MOOTHA_TCA	16	16		
MOOTHA_VOXPHOS	87	87		
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	76	73		
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	88	83		
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	174	169		
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	374	338		
MOREIRA_RESPONSE_TO_TSA_DN	18	18		
MOREIRA_RESPONSE_TO_TSA_UP	28	28		
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN	17	17		
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	111	110		
MORI_IMMATURE_B_LYMPHOCYTE_DN	91	91		
MORI_IMMATURE_B_LYMPHOCYTE_UP	52	50		
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN	60	59		
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	88	88		
MORI_MATURE_B_LYMPHOCYTE_DN	76	75		
MORI_MATURE_B_LYMPHOCYTE_UP	95	92		
MORI_PLASMA_CELL_DN	36	36		
MORI_PLASMA_CELL_UP	54	54		
MORI_PRE_BI_LYMPHOCYTE_DN	80	80		
MORI_PRE_BI_LYMPHOCYTE_UP	81	80		
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	75	73		
MORI_SMALL_PRE_BII_LYMPHOCYTE_UP	77	72		
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	12		Rejected!	
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	20	18		
MOSERLE_IFNA_RESPONSE	31	31		
MOTAMED_RESPONSE_TO_ANDROGEN_DN	6		Rejected!	
MOTAMED_RESPONSE_TO_ANDROGEN_UP	6		Rejected!	
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	33	31		
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	14		Rejected!	
MUELLER_METHYLATED_IN_GLIOBLASTOMA	43	32		
MUELLER_PLURINET	299	295		
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN	10		Rejected!	
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP	21	19		
MULLIGHAN_MLL_SIGNATURE_1_DN	238	224		
MULLIGHAN_MLL_SIGNATURE_1_UP	385	377		
MULLIGHAN_MLL_SIGNATURE_2_DN	279	269		
MULLIGHAN_MLL_SIGNATURE_2_UP	420	417		
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	125	117		
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	264	250		
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	76	70		
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	129	125		
MULLIGHAN_NPM1_SIGNATURE_3_DN	161	150		
MULLIGHAN_NPM1_SIGNATURE_3_UP	334	317		
MUNSHI_MULTIPLE_MYELOMA_DN	10		Rejected!	
MUNSHI_MULTIPLE_MYELOMA_UP	77	77		
MURAKAMI_UV_RESPONSE_1HR_DN	10		Rejected!	
MURAKAMI_UV_RESPONSE_1HR_UP	15		Rejected!	
MURAKAMI_UV_RESPONSE_24HR	20	18		
MURAKAMI_UV_RESPONSE_6HR_DN	21	19		
MURAKAMI_UV_RESPONSE_6HR_UP	34	33		
MURATA_VIRULENCE_OF_H_PILORI	22	21		
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1	6		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12	11		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13	6		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15	10		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16	9		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	19	16		
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18	5		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2	5		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21	6		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22	11		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	19	19		
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24	14		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25	9		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27	10		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29	8		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30	5		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5	6		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6	6		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7	7		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8	12		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9	8		Rejected!	
NABA_BASEMENT_MEMBRANES	40	40		
NABA_COLLAGENS	44	42		
NABA_CORE_MATRISOME	275	235		
NABA_ECM_AFFILIATED	170	145		
NABA_ECM_GLYCOPROTEINS	196	165		
NABA_ECM_REGULATORS	238	194		
NABA_MATRISOME	1026		Rejected!	
NABA_MATRISOME_ASSOCIATED	751		Rejected!	
NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS	59	54		
NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER	41	38		
NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED	29	27		
NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA	18	15		
NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED	12		Rejected!	
NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS	30	28		
NABA_MATRISOME_MULTIPLE_MYELOMA	10		Rejected!	
NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER	25	23		
NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED	12		Rejected!	
NABA_MATRISOME_POORLY_METASTATIC_MELANOMA	38	36		
NABA_MATRISOME_POORLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED	26	25		
NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR	59	54		
NABA_PROTEOGLYCANS	35	28		
NABA_SECRETED_FACTORS	343	272		
NADELLA_PRKAR1A_TARGETS_DN	7		Rejected!	
NADELLA_PRKAR1A_TARGETS_UP	9		Rejected!	
NADERI_BREAST_CANCER_PROGNOSIS_DN	18	16		
NADERI_BREAST_CANCER_PROGNOSIS_UP	51	45		
NADLER_HYPERGLYCEMIA_AT_OBESITY	59	54		
NADLER_OBESITY_DN	49	46		
NADLER_OBESITY_UP	60	59		
NAGASHIMA_EGF_SIGNALING_UP	57	57		
NAGASHIMA_NRG1_SIGNALING_DN	54	51		
NAGASHIMA_NRG1_SIGNALING_UP	172	168		
NAGY_PCAF_COMPONENTS_HUMAN	9		Rejected!	
NAGY_STAGA_COMPONENTS_HUMAN	13		Rejected!	
NAGY_TFTC_COMPONENTS_HUMAN	18	18		
NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF	8		Rejected!	
NAKAJIMA_EOSINOPHIL	25	25		
NAKAJIMA_MAST_CELL	46	44		
NAKAMURA_ADIPOGENESIS_EARLY_DN	35	32		
NAKAMURA_ADIPOGENESIS_EARLY_UP	63	58		
NAKAMURA_ADIPOGENESIS_LATE_DN	35	33		
NAKAMURA_ADIPOGENESIS_LATE_UP	98	97		
NAKAMURA_ALVEOLAR_EPITHELIUM	5		Rejected!	
NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA	7		Rejected!	
NAKAMURA_CANCER_MICROENVIRONMENT_DN	46	45		
NAKAMURA_CANCER_MICROENVIRONMENT_UP	28	23		
NAKAMURA_LUNG_CANCER	9		Rejected!	
NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS	13		Rejected!	
NAKAMURA_METASTASIS	47	44		
NAKAMURA_METASTASIS_MODEL_DN	44	42		
NAKAMURA_METASTASIS_MODEL_UP	45	41		
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	648		Rejected!	
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	284	270		
NAKAYAMA_FRA2_TARGETS	44	43		
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	77	66		
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	83	79		
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	85	80		
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	89	79		
NAM_FXYD5_TARGETS_DN	18	18		
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	51	48		
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	70	67		
NEBEN_AML_WITH_FLT3_OR_NRAS_DN	12		Rejected!	
NEBEN_AML_WITH_FLT3_OR_NRAS_UP	8		Rejected!	
NELSON_RESPONSE_TO_ANDROGEN_DN	17	15		
NELSON_RESPONSE_TO_ANDROGEN_UP	83	78		
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	30	29		
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	84	84		
NEWMAN_ERCC6_TARGETS_DN	39	31		
NEWMAN_ERCC6_TARGETS_UP	26	24		
NGO_MALIGNANT_GLIOMA_1P_LOH	15	15		
NGUYEN_NOTCH1_TARGETS_DN	83	82		
NGUYEN_NOTCH1_TARGETS_UP	27	27		
NICK_RESPONSE_TO_PROC_TREATMENT_DN	27	27		
NICK_RESPONSE_TO_PROC_TREATMENT_UP	5		Rejected!	
NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON	8		Rejected!	
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	158	145		
NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	46	44		
NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	15		Rejected!	
NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON	14		Rejected!	
NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	22	21		
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	119	111		
NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	52	51		
NIKOLSKY_BREAST_CANCER_17P11_AMPLICON	10		Rejected!	
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	132	103		
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	334	305		
NIKOLSKY_BREAST_CANCER_19P13_AMPLICON	5		Rejected!	
NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON	22	22		
NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON	7		Rejected!	
NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	38	37		
NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON	13		Rejected!	
NIKOLSKY_BREAST_CANCER_20P13_AMPLICON	8		Rejected!	
NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	31	30		
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	149	131		
NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	16	15		
NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	17	16		
NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	26	21		
NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	21	21		
NIKOLSKY_BREAST_CANCER_7P15_AMPLICON	11		Rejected!	
NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	38	36		
NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	75	70		
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	57	49		
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	132	121		
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	157	148		
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	94	89		
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	21	20		
NOJIMA_SFRP2_TARGETS_DN	26	24		
NOJIMA_SFRP2_TARGETS_UP	32	31		
NOURUZI_NEPC_ASCL1_TARGETS	159	134		
NOUSHMEHR_GBM_GERMLINE_MUTATED	8		Rejected!	
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION	50	42		
NOUSHMEHR_GBM_SOMATIC_MUTATED	9		Rejected!	
NOUZOVA_METHYLATED_IN_APL	66	54		
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	138	135		
NUMATA_CSF3_SIGNALING_VIA_STAT3	21	21		
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	13		Rejected!	
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	29	29		
NUTT_GBM_VS_AO_GLIOMA_DN	46	34		
NUTT_GBM_VS_AO_GLIOMA_UP	46	45		
NUYTTEN_EZH2_TARGETS_DN	1023		Rejected!	
NUYTTEN_EZH2_TARGETS_UP	1033		Rejected!	
NUYTTEN_NIPP1_TARGETS_DN	845		Rejected!	
NUYTTEN_NIPP1_TARGETS_UP	768		Rejected!	
ODONNELL_METASTASIS_DN	24	21		
ODONNELL_METASTASIS_UP	75	66		
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	47	46		
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	82	81		
ODONNELL_TFRC_TARGETS_DN	140	129		
ODONNELL_TFRC_TARGETS_UP	440	387		
OHASHI_AURKA_TARGETS	5		Rejected!	
OHASHI_AURKB_TARGETS	8		Rejected!	
OHGUCHI_LIVER_HNF4A_TARGETS_DN	171	146		
OHGUCHI_LIVER_HNF4A_TARGETS_UP	50	42		
OHM_EMBRYONIC_CARCINOMA_DN	8		Rejected!	
OHM_EMBRYONIC_CARCINOMA_UP	6		Rejected!	
OHM_METHYLATED_IN_ADULT_CANCERS	27	26		
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN	274	262		
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP	348	334		
OKAWA_NEUROBLASTOMA_1P36_31_DELETION	22	20		
OKUMURA_INFLAMMATORY_RESPONSE_LPS	182	176		
OLSSON_E2F3_TARGETS_DN	39	37		
OLSSON_E2F3_TARGETS_UP	26	26		
ONDER_CDH1_SIGNALING_VIA_CTNNB1	84	79		
ONDER_CDH1_TARGETS_1_DN	170	157		
ONDER_CDH1_TARGETS_1_UP	140	137		
ONDER_CDH1_TARGETS_2_DN	473	427		
ONDER_CDH1_TARGETS_2_UP	257	249		
ONDER_CDH1_TARGETS_3_DN	59	48		
ONDER_CDH1_TARGETS_3_UP	18	17		
ONGUSAHA_BRCA1_TARGETS_DN	11		Rejected!	
ONGUSAHA_BRCA1_TARGETS_UP	13		Rejected!	
ONGUSAHA_TP53_TARGETS	38	36		
ONKEN_UVEAL_MELANOMA_DN	533	499		
ONKEN_UVEAL_MELANOMA_UP	790		Rejected!	
ONO_AML1_TARGETS_DN	39	37		
ONO_AML1_TARGETS_UP	24	24		
ONO_FOXP3_TARGETS_DN	41	39		
ONO_FOXP3_TARGETS_UP	23	23		
OSADA_ASCL1_TARGETS_DN	24	23		
OSADA_ASCL1_TARGETS_UP	46	38		
OSAWA_TNF_TARGETS	10		Rejected!	
OSMAN_BLADDER_CANCER_DN	431	381		
OSMAN_BLADDER_CANCER_UP	401	400		
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	281	272		
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	224	220		
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	35	26		
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	69	68		
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	12		Rejected!	
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	118	116		
OUILLETTE_CLL_13Q14_DELETION_DN	56	55		
OUILLETTE_CLL_13Q14_DELETION_UP	75	71		
OUYANG_PROSTATE_CANCER_MARKERS	21	21		
OUYANG_PROSTATE_CANCER_PROGRESSION_DN	21	21		
OUYANG_PROSTATE_CANCER_PROGRESSION_UP	21	21		
OZANNE_AP1_TARGETS_UP	14		Rejected!	
OZEN_MIR125B1_TARGETS	23	21		
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	36	36		
PALOMERO_GSI_SENSITIVITY_DN	5		Rejected!	
PALOMERO_GSI_SENSITIVITY_UP	7		Rejected!	
PAL_PRMT5_TARGETS_DN	30	26		
PAL_PRMT5_TARGETS_UP	204	198		
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	148	141		
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	134	130		
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	43	41		
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	53	53		
PARENT_MTOR_SIGNALING_DN	44	40		
PARENT_MTOR_SIGNALING_UP	567		Rejected!	
PARK_APL_PATHOGENESIS_DN	48	48		
PARK_APL_PATHOGENESIS_UP	14		Rejected!	
PARK_HSC_AND_MULTIPOTENT_PROGENITORS	45	44		
PARK_HSC_MARKERS	44	43		
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN	15		Rejected!	
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP	19	19		
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN	6		Rejected!	
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP	12		Rejected!	
PARK_TRETINOIN_RESPONSE	12		Rejected!	
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	30	30		
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	23	23		
PASINI_SUZ12_TARGETS_DN	316	309		
PASINI_SUZ12_TARGETS_UP	112	101		
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	170	169		
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	286	281		
PASTURAL_RIZ1_TARGETS_DN	5		Rejected!	
PASTURAL_RIZ1_TARGETS_UP	10		Rejected!	
PATIL_LIVER_CANCER	660		Rejected!	
PEART_HDAC_PROLIFERATION_CLUSTER_DN	71	71		
PEART_HDAC_PROLIFERATION_CLUSTER_UP	53	53		
PECE_MAMMARY_STEM_CELL_DN	143	142		
PECE_MAMMARY_STEM_CELL_UP	140	99		
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1	46	46		
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3	20	18		
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	108	102		
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5	11		Rejected!	
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6	29	26		
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	399	385		
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	75	73		
PEDRIOLI_MIR31_TARGETS_DN	413	398		
PEDRIOLI_MIR31_TARGETS_UP	223	191		
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	49	49		
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	64	64		
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	23	19		
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	32	28		
PEREZ_TP53_AND_TP63_TARGETS	207	198		
PEREZ_TP53_TARGETS	1201		Rejected!	
PEREZ_TP63_TARGETS	356	336		
PETRETTO_BLOOD_PRESSURE_DN	8		Rejected!	
PETRETTO_BLOOD_PRESSURE_UP	12		Rejected!	
PETRETTO_CARDIAC_HYPERTROPHY	34	34		
PETRETTO_HEART_MASS_QTL_CIS_DN	28	27		
PETRETTO_HEART_MASS_QTL_CIS_UP	32	32		
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN	10		Rejected!	
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP	6		Rejected!	
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	162	158		
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	131	130		
PETROVA_PROX1_TARGETS_DN	56	55		
PETROVA_PROX1_TARGETS_UP	25	25		
PHESSE_TARGETS_OF_APC_AND_MBD2_DN	11		Rejected!	
PHESSE_TARGETS_OF_APC_AND_MBD2_UP	18	16		
PHONG_TNF_RESPONSE_NOT_VIA_P38	341	333		
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	224	224		
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	164	159		
PHONG_TNF_TARGETS_DN	8		Rejected!	
PHONG_TNF_TARGETS_UP	63	63		
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	137	137		
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	211	204		
PIEPOLI_LGI1_TARGETS_DN	17	15		
PIEPOLI_LGI1_TARGETS_UP	17		Rejected!	
PILON_KLF1_TARGETS_UP	498	468		
PIONTEK_PKD1_TARGETS_DN	18	15		
PIONTEK_PKD1_TARGETS_UP	42	37		
PLASARI_NFIC_TARGETS_BASAL_DN	21	20		
PLASARI_NFIC_TARGETS_BASAL_UP	30	25		
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN	33	31		
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP	58	54		
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	109	103		
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP	33	32		
PLASARI_TGFB1_TARGETS_10HR_DN	256	243		
PLASARI_TGFB1_TARGETS_10HR_UP	196	186		
PLASARI_TGFB1_TARGETS_1HR_DN	5		Rejected!	
PLASARI_TGFB1_TARGETS_1HR_UP	33	33		
PODAR_RESPONSE_TO_ADAPHOSTIN_DN	18	17		
PODAR_RESPONSE_TO_ADAPHOSTIN_UP	148	148		
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	61	46		
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	63	62		
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	44	31		
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	48	46		
POOLA_INVASIVE_BREAST_CANCER_DN	133	116		
POOLA_INVASIVE_BREAST_CANCER_UP	292	283		
POS_HISTAMINE_RESPONSE_NETWORK	31	30		
POS_RESPONSE_TO_HISTAMINE_DN	11		Rejected!	
POS_RESPONSE_TO_HISTAMINE_UP	12		Rejected!	
PRAMOONJAGO_SOX4_TARGETS_DN	49	48		
PRAMOONJAGO_SOX4_TARGETS_UP	52	51		
PROVENZANI_METASTASIS_DN	142	132		
PROVENZANI_METASTASIS_UP	204	197		
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	146	141		
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	79	78		
PUJANA_ATM_PCC_NETWORK	1393		Rejected!	
PUJANA_BRCA1_PCC_NETWORK	1625		Rejected!	
PUJANA_BRCA2_PCC_NETWORK	426	424		
PUJANA_BRCA_CENTERED_NETWORK	118	118		
PUJANA_BREAST_CANCER_LIT_INT_NETWORK	101	101		
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN	9		Rejected!	
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	55	55		
PUJANA_CHEK2_PCC_NETWORK	761		Rejected!	
PUJANA_XPRSS_INT_NETWORK	168	168		
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	161	153		
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	77	72		
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	403	370		
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP	296	276		
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN	29	21		
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	194	190		
PYEON_HPV_POSITIVE_TUMORS_DN	10		Rejected!	
PYEON_HPV_POSITIVE_TUMORS_UP	101	97		
QI_HYPOXIA	133	127		
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2	35	34		
QI_PLASMACYTOMA_DN	98	94		
QI_PLASMACYTOMA_UP	254	251		
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR	82	80		
RADAEVA_RESPONSE_TO_IFNA1_DN	10		Rejected!	
RADAEVA_RESPONSE_TO_IFNA1_UP	47	46		
RADMACHER_AML_PROGNOSIS	81	80		
RAFFEL_VEGFA_TARGETS_DN	5		Rejected!	
RAFFEL_VEGFA_TARGETS_UP	9		Rejected!	
RAGHAVACHARI_PLATELET_SPECIFIC_GENES	71	71		
RAHMAN_TP53_TARGETS_PHOSPHORYLATED	20	20		
RAMALHO_STEMNESS_DN	72	71		
RAMALHO_STEMNESS_UP	196	188		
RAMASWAMY_METASTASIS_DN	59	58		
RAMASWAMY_METASTASIS_UP	66	65		
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN	8		Rejected!	
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP	6		Rejected!	
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN	10		Rejected!	
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP	10		Rejected!	
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN	10		Rejected!	
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP	14		Rejected!	
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP	21	20		
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN	8		Rejected!	
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP	5		Rejected!	
RAO_BOUND_BY_SALL4	226	212		
RAO_BOUND_BY_SALL4_ISOFORM_A	194	153		
RAO_BOUND_BY_SALL4_ISOFORM_B	526	480		
RASHI_NFKB1_TARGETS	18	18		
RASHI_RESPONSE_TO_IONIZING_RADIATION_1	39	38		
RASHI_RESPONSE_TO_IONIZING_RADIATION_2	125	120		
RASHI_RESPONSE_TO_IONIZING_RADIATION_3	47	45		
RASHI_RESPONSE_TO_IONIZING_RADIATION_4	48	46		
RASHI_RESPONSE_TO_IONIZING_RADIATION_5	133	125		
RASHI_RESPONSE_TO_IONIZING_RADIATION_6	95	90		
RATTENBACHER_BOUND_BY_CELF1	443	418		
RAY_ALZHEIMERS_DISEASE	13		Rejected!	
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	15	15		
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	16		Rejected!	
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	266	256		
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	205	178		
REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS	8		Rejected!	
REICHERT_MITOSIS_LIN9_TARGETS	27	27		
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	407	403		
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	99	91		
REN_BOUND_BY_E2F	62	62		
REN_MIF_TARGETS_DN	5		Rejected!	
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	368	359		
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	76	75		
RHODES_CANCER_META_SIGNATURE	65	63		
RHODES_UNDIFFERENTIATED_CANCER	69	69		
RICKMAN_HEAD_AND_NECK_CANCER_A	105	93		
RICKMAN_HEAD_AND_NECK_CANCER_B	55	39		
RICKMAN_HEAD_AND_NECK_CANCER_C	116	88		
RICKMAN_HEAD_AND_NECK_CANCER_D	40	34		
RICKMAN_HEAD_AND_NECK_CANCER_E	88	69		
RICKMAN_HEAD_AND_NECK_CANCER_F	55	45		
RICKMAN_METASTASIS_DN	263	250		
RICKMAN_METASTASIS_UP	350	342		
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	16	16		
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	125	121		
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	113	92		
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	107	103		
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	384	363		
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	242	235		
RIEGE_DELTANP63_DIRECT_TARGETS_UP	138	134		
RIGGINS_TAMOXIFEN_RESISTANCE_DN	221	212		
RIGGINS_TAMOXIFEN_RESISTANCE_UP	67	65		
RIGGI_EWING_SARCOMA_PROGENITOR_DN	195	179		
RIGGI_EWING_SARCOMA_PROGENITOR_UP	437	407		
RIZKI_TUMOR_INVASIVENESS_2D_DN	63	59		
RIZKI_TUMOR_INVASIVENESS_2D_UP	69	66		
RIZKI_TUMOR_INVASIVENESS_3D_DN	262	247		
RIZKI_TUMOR_INVASIVENESS_3D_UP	209	197		
RIZ_ERYTHROID_DIFFERENTIATION	82	80		
RIZ_ERYTHROID_DIFFERENTIATION_12HR	37	35		
RIZ_ERYTHROID_DIFFERENTIATION_6HR	38	30		
RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2	25	21		
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	43	43		
RIZ_ERYTHROID_DIFFERENTIATION_HBZ	37	32		
RIZ_ERYTHROID_DIFFERENTIATION_HEMGN	26	23		
RODRIGUES_DCC_TARGETS_DN	119	118		
RODRIGUES_DCC_TARGETS_UP	6		Rejected!	
RODRIGUES_NTN1_AND_DCC_TARGETS	35	34		
RODRIGUES_NTN1_TARGETS_DN	161	153		
RODRIGUES_NTN1_TARGETS_UP	17	15		
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	537		Rejected!	
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	720		Rejected!	
RODRIGUES_THYROID_CARCINOMA_DN	77	75		
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	801		Rejected!	
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	644		Rejected!	
RODRIGUES_THYROID_CARCINOMA_UP	16	15		
RODWELL_AGING_KIDNEY_DN	148	141		
RODWELL_AGING_KIDNEY_NO_BLOOD_DN	148	142		
RODWELL_AGING_KIDNEY_NO_BLOOD_UP	224	204		
RODWELL_AGING_KIDNEY_UP	501	472		
ROESSLER_LIVER_CANCER_METASTASIS_DN	51	49		
ROESSLER_LIVER_CANCER_METASTASIS_UP	106	102		
ROETH_TERT_TARGETS_DN	9		Rejected!	
ROETH_TERT_TARGETS_UP	14		Rejected!	
ROPERO_HDAC2_TARGETS	112	102		
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	28	25		
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	28	28		
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	82	81		
ROSS_AML_OF_FAB_M7_TYPE	70	69		
ROSS_AML_WITH_AML1_ETO_FUSION	79	77		
ROSS_AML_WITH_CBFB_MYH11_FUSION	52	52		
ROSS_AML_WITH_MLL_FUSIONS	80	75		
ROSS_AML_WITH_PML_RARA_FUSION	80	79		
ROSS_LEUKEMIA_WITH_MLL_FUSIONS	79	77		
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	140	139		
ROVERSI_GLIOMA_COPY_NUMBER_DN	54	49		
ROVERSI_GLIOMA_COPY_NUMBER_UP	100	94		
ROVERSI_GLIOMA_LOH_REGIONS	45	39		
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	26	24		
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	64	61		
ROY_WOUND_BLOOD_VESSEL_DN	23	19		
ROY_WOUND_BLOOD_VESSEL_UP	50	48		
ROZANOV_MMP14_CORRELATED	11		Rejected!	
ROZANOV_MMP14_TARGETS_DN	35	33		
ROZANOV_MMP14_TARGETS_SUBSET	33	29		
ROZANOV_MMP14_TARGETS_UP	267	254		
RUAN_RESPONSE_TO_TNF_DN	79	76		
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN	39	37		
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	17		Rejected!	
RUAN_RESPONSE_TO_TNF_UP	13		Rejected!	
RUAN_RESPONSE_TO_TROGLITAZONE_DN	17	16		
RUAN_RESPONSE_TO_TROGLITAZONE_UP	24	22		
RUIZ_TNC_TARGETS_DN	143	140		
RUIZ_TNC_TARGETS_UP	156	150		
RUNNE_GENDER_EFFECT_UP	9		Rejected!	
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	320	316		
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	341	336		
RUTELLA_RESPONSE_TO_HGF_DN	240	237		
RUTELLA_RESPONSE_TO_HGF_UP	421	415		
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN	250	244		
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	411	408		
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP	148	146		
SABATES_COLORECTAL_ADENOMA_DN	299	257		
SABATES_COLORECTAL_ADENOMA_SIZE_DN	13		Rejected!	
SABATES_COLORECTAL_ADENOMA_SIZE_UP	23	23		
SABATES_COLORECTAL_ADENOMA_UP	140	117		
SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN	15		Rejected!	
SAFFORD_T_LYMPHOCYTE_ANERGY	90	85		
SAGIV_CD24_TARGETS_DN	45	44		
SAGIV_CD24_TARGETS_UP	22	22		
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	36	30		
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	82	81		
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	81	81		
SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	27	26		
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	16	15		
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP	26	26		
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP	29	29		
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	60	57		
SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP	8		Rejected!	
SANA_RESPONSE_TO_IFNG_DN	87	81		
SANA_RESPONSE_TO_IFNG_UP	76	74		
SANA_TNF_SIGNALING_DN	85	82		
SANA_TNF_SIGNALING_UP	83	80		
SANCHEZ_MDM2_TARGETS	15	15		
SANDERSON_PPARA_TARGETS	15		Rejected!	
SANSOM_APC_MYC_TARGETS	241	239		
SANSOM_APC_TARGETS	209	188		
SANSOM_APC_TARGETS_DN	366	345		
SANSOM_APC_TARGETS_REQUIRE_MYC	225	222		
SANSOM_APC_TARGETS_UP	132	122		
SANSOM_WNT_PATHWAY_REQUIRE_MYC	63	59		
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	145	134		
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	166	163		
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN	18	18		
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP	17	17		
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN	20	19		
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP	29	28		
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION	50	49		
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN	8		Rejected!	
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP	14		Rejected!	
SASAKI_ADULT_T_CELL_LEUKEMIA	168	165		
SASAKI_TARGETS_OF_TP73_AND_TP63	12		Rejected!	
SASSON_FSH_RESPONSE	7		Rejected!	
SASSON_RESPONSE_TO_FORSKOLIN_DN	85	84		
SASSON_RESPONSE_TO_FORSKOLIN_UP	88	85		
SASSON_RESPONSE_TO_GONADOTROPHINS_DN	86	85		
SASSON_RESPONSE_TO_GONADOTROPHINS_UP	86	83		
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	47	40		
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	422	379		
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	47	42		
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	46	38		
SAUL_SEN_MAYO	125	116		
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN	54	47		
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	110	96		
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	410	373		
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	449	409		
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	465	450		
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	158	154		
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN	10		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP	14		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN	7		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP	6		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3	5		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	33	33		
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP	11		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN	8		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP	11		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN	5		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP	7		Rejected!	
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN	45	42		
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP	21	21		
SCHAVOLT_TARGETS_OF_TP53_AND_TP63	15	15		
SCHEIDEREIT_IKK_INTERACTING_PROTEINS	53	51		
SCHEIDEREIT_IKK_TARGETS	18	18		
SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	28	20		
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	88	76		
SCHLESINGER_METHYLATED_IN_COLON_CANCER	10		Rejected!	
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN	26	25		
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP	40	33		
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	33	31		
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	48	47		
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	48	48		
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	161	158		
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	106	104		
SCHLOSSER_SERUM_RESPONSE_DN	705		Rejected!	
SCHLOSSER_SERUM_RESPONSE_UP	126	122		
SCHMAHL_PDGF_SIGNALING	10		Rejected!	
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN	8		Rejected!	
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP	27	26		
SCHOEN_NFKB_SIGNALING	34	33		
SCHRAETS_MLL_TARGETS_DN	33	30		
SCHRAETS_MLL_TARGETS_UP	33	30		
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	85	76		
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	352	339		
SCHUHMACHER_MYC_TARGETS_DN	8		Rejected!	
SCHUHMACHER_MYC_TARGETS_UP	80	79		
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN	16	16		
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP	13		Rejected!	
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	22	22		
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP	9		Rejected!	
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	30	30		
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP	11		Rejected!	
SCIBETTA_KDM5B_TARGETS_DN	79	77		
SCIBETTA_KDM5B_TARGETS_UP	19	19		
SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA	93	86		
SEIDEN_MET_SIGNALING	20	20		
SEIDEN_ONCOGENESIS_BY_MET	89	89		
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	32	30		
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	75	69		
SEKI_INFLAMMATORY_RESPONSE_LPS_DN	23	22		
SEKI_INFLAMMATORY_RESPONSE_LPS_UP	76	73		
SEMBA_FHIT_TARGETS_DN	10		Rejected!	
SEMBA_FHIT_TARGETS_UP	11		Rejected!	
SEMENZA_HIF1_TARGETS	36	33		
SENESE_HDAC1_AND_HDAC2_TARGETS_DN	238	222		
SENESE_HDAC1_AND_HDAC2_TARGETS_UP	243	233		
SENESE_HDAC1_TARGETS_DN	267	252		
SENESE_HDAC1_TARGETS_UP	451	440		
SENESE_HDAC2_TARGETS_DN	133	121		
SENESE_HDAC2_TARGETS_UP	116	113		
SENESE_HDAC3_TARGETS_DN	548		Rejected!	
SENESE_HDAC3_TARGETS_UP	495	482		
SENGUPTA_EBNA1_ANTICORRELATED	161	154		
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	358	321		
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	304	301		
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	175	148		
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	405	388		
SERVITJA_ISLET_HNF1A_TARGETS_DN	110	93		
SERVITJA_ISLET_HNF1A_TARGETS_UP	167	153		
SERVITJA_LIVER_HNF1A_TARGETS_DN	166	140		
SERVITJA_LIVER_HNF1A_TARGETS_UP	136	129		
SESTO_RESPONSE_TO_UV_C0	109	104		
SESTO_RESPONSE_TO_UV_C1	74	70		
SESTO_RESPONSE_TO_UV_C2	54	54		
SESTO_RESPONSE_TO_UV_C3	22	21		
SESTO_RESPONSE_TO_UV_C4	20	18		
SESTO_RESPONSE_TO_UV_C5	46	46		
SESTO_RESPONSE_TO_UV_C6	39	38		
SESTO_RESPONSE_TO_UV_C7	70	69		
SESTO_RESPONSE_TO_UV_C8	71	68		
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	20	15		
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	67	67		
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	36	36		
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	81	81		
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	65	65		
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	101	101		
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	67	67		
SHANK_TAL1_TARGETS_DN	10		Rejected!	
SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM	5		Rejected!	
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN	7		Rejected!	
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	27	23		
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	318	290		
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	197	188		
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	69	68		
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	459	442		
SHEN_SMARCA2_TARGETS_DN	321	265		
SHEN_SMARCA2_TARGETS_UP	428	427		
SHEPARD_BMYB_MORPHOLINO_DN	202	179		
SHEPARD_BMYB_MORPHOLINO_UP	212	203		
SHEPARD_BMYB_TARGETS	76	71		
SHEPARD_CRASH_AND_BURN_MUTANT_DN	191	176		
SHEPARD_CRASH_AND_BURN_MUTANT_UP	205	190		
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	260	249		
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	168	164		
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	74	71		
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4	288	270		
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5	108	101		
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	55	51		
SHIN_B_CELL_LYMPHOMA_CLUSTER_1	13		Rejected!	
SHIN_B_CELL_LYMPHOMA_CLUSTER_2	31	27		
SHIN_B_CELL_LYMPHOMA_CLUSTER_3	28	28		
SHIN_B_CELL_LYMPHOMA_CLUSTER_5	18		Rejected!	
SHIN_B_CELL_LYMPHOMA_CLUSTER_6	12		Rejected!	
SHIN_B_CELL_LYMPHOMA_CLUSTER_7	27	25		
SHIN_B_CELL_LYMPHOMA_CLUSTER_8	37	37		
SHIN_B_CELL_LYMPHOMA_CLUSTER_9	19	17		
SHIPP_DLBCL_CURED_VS_FATAL_DN	44	43		
SHIPP_DLBCL_CURED_VS_FATAL_UP	39	37		
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	45	44		
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	45	45		
SHIRAISHI_PLZF_TARGETS_DN	9		Rejected!	
SHIRAISHI_PLZF_TARGETS_UP	10		Rejected!	
SHI_SPARC_TARGETS_DN	13		Rejected!	
SHI_SPARC_TARGETS_UP	24	22		
SILIGAN_BOUND_BY_EWS_FLT1_FUSION	46	44		
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	18	17		
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP	15		Rejected!	
SIMBULAN_PARP1_TARGETS_DN	17	17		
SIMBULAN_PARP1_TARGETS_UP	30	29		
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	31	31		
SIMBULAN_UV_RESPONSE_NORMAL_DN	33	32		
SIMBULAN_UV_RESPONSE_NORMAL_UP	9		Rejected!	
SINGH_NFE2L2_TARGETS	14		Rejected!	
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	79	74		
SMID_BREAST_CANCER_BASAL_DN	700		Rejected!	
SMID_BREAST_CANCER_BASAL_UP	662		Rejected!	
SMID_BREAST_CANCER_ERBB2_DN	5		Rejected!	
SMID_BREAST_CANCER_ERBB2_UP	152	136		
SMID_BREAST_CANCER_LUMINAL_A_DN	18	16		
SMID_BREAST_CANCER_LUMINAL_A_UP	85	79		
SMID_BREAST_CANCER_LUMINAL_B_DN	587		Rejected!	
SMID_BREAST_CANCER_LUMINAL_B_UP	169	149		
SMID_BREAST_CANCER_NORMAL_LIKE_DN	6		Rejected!	
SMID_BREAST_CANCER_NORMAL_LIKE_UP	485	474		
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	324	283		
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	99	87		
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	82	78		
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	41	36		
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN	10		Rejected!	
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP	6		Rejected!	
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	38	29		
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	22	19		
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	32	26		
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP	6		Rejected!	
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN	5		Rejected!	
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	159	157		
SMIRNOV_RESPONSE_TO_IR_2HR_DN	57	57		
SMIRNOV_RESPONSE_TO_IR_2HR_UP	53	52		
SMIRNOV_RESPONSE_TO_IR_6HR_DN	114	114		
SMIRNOV_RESPONSE_TO_IR_6HR_UP	168	165		
SMITH_LIVER_CANCER	47	46		
SMITH_TERT_TARGETS_DN	87	85		
SMITH_TERT_TARGETS_UP	145	142		
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	37	35		
SOGA_COLORECTAL_CANCER_MYC_DN	71	68		
SOGA_COLORECTAL_CANCER_MYC_UP	82	81		
SONG_TARGETS_OF_IE86_CMV_PROTEIN	55	55		
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	53	52		
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	154	150		
SOUCEK_MYC_TARGETS	10		Rejected!	
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	21	21		
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP	13		Rejected!	
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	590		Rejected!	
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	484	466		
SPIRA_SMOKERS_LUNG_CANCER_DN	14		Rejected!	
SPIRA_SMOKERS_LUNG_CANCER_UP	39	36		
STAEGE_EWING_FAMILY_TUMOR	32	26		
STAMBOLSKY_BOUND_BY_MUTATED_TP53	18	15		
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN	25	24		
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	84	74		
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN	51	48		
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP	49	46		
STANELLE_E2F1_TARGETS	29	27		
STANHILL_HRAS_TRANSFROMATION_UP	5		Rejected!	
STARK_BRAIN_22Q11_DELETION	16		Rejected!	
STARK_HYPPOCAMPUS_22Q11_DELETION_DN	23	22		
STARK_HYPPOCAMPUS_22Q11_DELETION_UP	54	52		
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	526	493		
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	202	196		
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	63	60		
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	127	126		
STEARMAN_TUMOR_FIELD_EFFECT_UP	38	35		
STEGER_ADIPOGENESIS_DN	25	23		
STEGER_ADIPOGENESIS_UP	21	19		
STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS	11		Rejected!	
STEINER_ERYTHROCYTE_MEMBRANE_GENES	14		Rejected!	
STEIN_ESR1_TARGETS	83	79		
STEIN_ESRRA_TARGETS	529		Rejected!	
STEIN_ESRRA_TARGETS_DN	105	102		
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	41	40		
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	30	28		
STEIN_ESRRA_TARGETS_UP	385	370		
STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18	16		
STONER_ESOPHAGEAL_CARCINOGENESIS_DN	7		Rejected!	
STONER_ESOPHAGEAL_CARCINOGENESIS_UP	38	36		
STOSSI_RESPONSE_TO_ESTRADIOL	46	40		
STREICHER_LSM1_TARGETS_DN	19	19		
STREICHER_LSM1_TARGETS_UP	44	44		
SUBTIL_PROGESTIN_TARGETS	36	36		
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	18	18		
SUMI_HNF4A_TARGETS	30	25		
SUNG_METASTASIS_STROMA_DN	54	51		
SUNG_METASTASIS_STROMA_UP	110	106		
SUZUKI_AMPLIFIED_IN_ORAL_CANCER	17		Rejected!	
SUZUKI_CTCFL_TARGETS_UP	13		Rejected!	
SUZUKI_RESPONSE_TO_TSA	18	16		
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A	21	20		
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B	16	15		
SU_KIDNEY	15		Rejected!	
SU_LIVER	58	44		
SU_PANCREAS	48	41		
SU_PLACENTA	30	23		
SU_SALIVARY_GLAND	14		Rejected!	
SU_TESTIS	80	67		
SU_THYMUS	20	18		
SWEET_KRAS_ONCOGENIC_SIGNATURE	89	83		
SWEET_KRAS_TARGETS_DN	66	60		
SWEET_KRAS_TARGETS_UP	83	81		
SWEET_LUNG_CANCER_KRAS_DN	421	388		
SWEET_LUNG_CANCER_KRAS_UP	481	446		
SYED_ESTRADIOL_RESPONSE	18	17		
TAGHAVI_NEOPLASTIC_TRANSFORMATION	11		Rejected!	
TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN	29	26		
TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP	7		Rejected!	
TAKAO_RESPONSE_TO_UVB_RADIATION_DN	98	97		
TAKAO_RESPONSE_TO_UVB_RADIATION_UP	87	75		
TAKAYAMA_BOUND_BY_AR	10		Rejected!	
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	150	142		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	193	186		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	131	129		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	176	172		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	30	28		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	183	178		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	45	44		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	86	83		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	205	195		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	156	149		
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	102	77		
TANG_SENESCENCE_TP53_TARGETS_DN	56	54		
TANG_SENESCENCE_TP53_TARGETS_UP	33	32		
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN	38	37		
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	81	81		
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	307	303		
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP	397	336		
TAVAZOIE_METASTASIS	108	91		
TAVOR_CEBPA_TARGETS_DN	32	32		
TAVOR_CEBPA_TARGETS_UP	51	51		
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	78	74		
TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	31	30		
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	75	71		
TCGA_GLIOBLASTOMA_MUTATED	8		Rejected!	
TENEDINI_MEGAKARYOCYTE_MARKERS	62	62		
TERAMOTO_OPN_TARGETS_CLUSTER_1	14		Rejected!	
TERAMOTO_OPN_TARGETS_CLUSTER_3	7		Rejected!	
TERAMOTO_OPN_TARGETS_CLUSTER_4	15		Rejected!	
TERAMOTO_OPN_TARGETS_CLUSTER_5	7		Rejected!	
TERAMOTO_OPN_TARGETS_CLUSTER_6	26	26		
TERAMOTO_OPN_TARGETS_CLUSTER_7	18	18		
TERAMOTO_OPN_TARGETS_CLUSTER_8	8		Rejected!	
TERAO_AOX4_TARGETS_HG_DN	6		Rejected!	
TERAO_AOX4_TARGETS_HG_UP	28	28		
TERAO_AOX4_TARGETS_SKIN_DN	23	23		
TERAO_AOX4_TARGETS_SKIN_UP	31	28		
TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN	6		Rejected!	
TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP	5		Rejected!	
TESAR_ALK_TARGETS_EPISC_3D_UP	7		Rejected!	
TESAR_ALK_TARGETS_EPISC_4D_UP	6		Rejected!	
TESAR_ALK_TARGETS_HUMAN_ES_4D_DN	6		Rejected!	
TESAR_ALK_TARGETS_HUMAN_ES_5D_DN	7		Rejected!	
TESAR_ALK_TARGETS_HUMAN_ES_5D_UP	5		Rejected!	
TESAR_JAK_TARGETS_MOUSE_ES_D3_DN	8		Rejected!	
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN	227	226		
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	76	74		
THEODOROU_MAMMARY_TUMORIGENESIS	31	27		
THILLAINADESAN_ZNF217_TARGETS_DN	9		Rejected!	
THILLAINADESAN_ZNF217_TARGETS_UP	41	40		
THUM_MIR21_TARGETS_HEART_DISEASE_DN	9		Rejected!	
THUM_MIR21_TARGETS_HEART_DISEASE_UP	18	17		
THUM_SYSTOLIC_HEART_FAILURE_DN	220	216		
THUM_SYSTOLIC_HEART_FAILURE_UP	430	414		
TIAN_BHLHA15_TARGETS	16	16		
TIAN_TNF_SIGNALING_NOT_VIA_NFKB	22	22		
TIAN_TNF_SIGNALING_VIA_NFKB	26	26		
TIEN_INTESTINE_PROBIOTICS_24HR_DN	215	187		
TIEN_INTESTINE_PROBIOTICS_24HR_UP	561		Rejected!	
TIEN_INTESTINE_PROBIOTICS_2HR_DN	89	88		
TIEN_INTESTINE_PROBIOTICS_2HR_UP	30	24		
TIEN_INTESTINE_PROBIOTICS_6HR_DN	170	168		
TIEN_INTESTINE_PROBIOTICS_6HR_UP	53	33		
TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	16	16		
TING_SILENCED_BY_DICER	30	26		
TOMIDA_LUNG_CANCER_POOR_SURVIVAL	5		Rejected!	
TOMIDA_METASTASIS_DN	18	18		
TOMIDA_METASTASIS_UP	26	24		
TOMLINS_METASTASIS_DN	20	20		
TOMLINS_METASTASIS_UP	14		Rejected!	
TOMLINS_PROSTATE_CANCER_DN	40	39		
TOMLINS_PROSTATE_CANCER_UP	40	39		
TONG_INTERACT_WITH_PTTG1	57	50		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	18	18		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	159	156		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	18	18		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	54	54		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	193	192		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	184	179		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	56	56		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	203	200		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	44	44		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN	7		Rejected!	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	15	15		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN	10		Rejected!	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	21	21		
TOOKER_GEMCITABINE_RESISTANCE_DN	123	120		
TOOKER_GEMCITABINE_RESISTANCE_UP	80	76		
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN	323	319		
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN	18	18		
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP	20	20		
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP	272	266		
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	454	451		
TRAYNOR_RETT_SYNDROM_DN	15	15		
TRAYNOR_RETT_SYNDROM_UP	40	38		
TSAI_DNAJB4_TARGETS_DN	6		Rejected!	
TSAI_DNAJB4_TARGETS_UP	13		Rejected!	
TSAI_RESPONSE_TO_IONIZING_RADIATION	150	144		
TSAI_RESPONSE_TO_RADIATION_THERAPY	32	32		
TSENG_ADIPOGENIC_POTENTIAL_DN	47	41		
TSENG_ADIPOGENIC_POTENTIAL_UP	30	29		
TSENG_IRS1_TARGETS_DN	134	127		
TSENG_IRS1_TARGETS_UP	116	109		
TSUDA_ALVEOLAR_SOFT_PART_SARCOMA	10		Rejected!	
TSUNODA_CISPLATIN_RESISTANCE_DN	50	47		
TSUNODA_CISPLATIN_RESISTANCE_UP	15	15		
TSUTSUMI_FBXW8_TARGETS	9		Rejected!	
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN	19		Rejected!	
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP	20	16		
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN	7		Rejected!	
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	24	24		
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	206	190		
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	47	46		
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	73	66		
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	74	71		
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	92	85		
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	69	65		
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	74	70		
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	96	90		
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN	7		Rejected!	
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	66	65		
TURJANSKI_MAPK11_TARGETS	5		Rejected!	
TURJANSKI_MAPK14_TARGETS	10		Rejected!	
TURJANSKI_MAPK1_AND_MAPK2_TARGETS	12		Rejected!	
TURJANSKI_MAPK7_TARGETS	7		Rejected!	
TURJANSKI_MAPK8_AND_MAPK9_TARGETS	8		Rejected!	
UDAYAKUMAR_MED1_TARGETS_DN	244	237		
UDAYAKUMAR_MED1_TARGETS_UP	136	132		
UEDA_CENTRAL_CLOCK	90	84		
UEDA_PERIFERAL_CLOCK	171	162		
ULE_SPLICING_VIA_NOVA2	43	41		
UROSEVIC_RESPONSE_TO_IMIQUIMOD	19	19		
URS_ADIPOCYTE_DIFFERENTIATION_DN	31	29		
URS_ADIPOCYTE_DIFFERENTIATION_UP	66	62		
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	36	36		
VALK_AML_CLUSTER_1	29	29		
VALK_AML_CLUSTER_10	33	33		
VALK_AML_CLUSTER_11	38	38		
VALK_AML_CLUSTER_12	30	30		
VALK_AML_CLUSTER_13	31	30		
VALK_AML_CLUSTER_15	31	31		
VALK_AML_CLUSTER_16	28	26		
VALK_AML_CLUSTER_2	29	28		
VALK_AML_CLUSTER_3	34	34		
VALK_AML_CLUSTER_4	30	30		
VALK_AML_CLUSTER_5	32	32		
VALK_AML_CLUSTER_6	34	32		
VALK_AML_CLUSTER_7	27	27		
VALK_AML_CLUSTER_8	25	25		
VALK_AML_CLUSTER_9	35	35		
VALK_AML_WITH_11Q23_REARRANGED	23	21		
VALK_AML_WITH_CEBPA	37	37		
VALK_AML_WITH_EVI1	25	25		
VALK_AML_WITH_FLT3_ITD	41	41		
VALK_AML_WITH_T_8_21_TRANSLOCATION	5		Rejected!	
VANASSE_BCL2_TARGETS_DN	61	61		
VANASSE_BCL2_TARGETS_UP	34	32		
VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP	15		Rejected!	
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	37	32		
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP	82	74		
VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN	17		Rejected!	
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP	17		Rejected!	
VANDESLUIS_NORMAL_EMBRYOS_DN	21	20		
VANDESLUIS_NORMAL_EMBRYOS_UP	5		Rejected!	
VANHARANTA_UTERINE_FIBROID_DN	67	65		
VANHARANTA_UTERINE_FIBROID_UP	44	42		
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	36	35		
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	66	65		
VANLOO_SP3_TARGETS_DN	89	86		
VANLOO_SP3_TARGETS_UP	9		Rejected!	
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS	221	211		
VANTVEER_BREAST_CANCER_BRCA1_DN	41	37		
VANTVEER_BREAST_CANCER_BRCA1_UP	34	34		
VANTVEER_BREAST_CANCER_ESR1_DN	224	217		
VANTVEER_BREAST_CANCER_ESR1_UP	149	146		
VANTVEER_BREAST_CANCER_METASTASIS_DN	109	107		
VANTVEER_BREAST_CANCER_METASTASIS_UP	45	43		
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	49	49		
VARELA_ZMPSTE24_TARGETS_DN	42	39		
VARELA_ZMPSTE24_TARGETS_UP	44	43		
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	134	121		
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	163	153		
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	146	128		
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	177	165		
VECCHI_GASTRIC_CANCER_EARLY_DN	383	342		
VECCHI_GASTRIC_CANCER_EARLY_UP	435	418		
VERHAAK_AML_WITH_NPM1_MUTATED_DN	250	248		
VERHAAK_AML_WITH_NPM1_MUTATED_UP	187	183		
VERHAAK_GLIOBLASTOMA_CLASSICAL	161	155		
VERHAAK_GLIOBLASTOMA_MESENCHYMAL	216	215		
VERHAAK_GLIOBLASTOMA_NEURAL	128	119		
VERHAAK_GLIOBLASTOMA_PRONEURAL	177	168		
VERNELL_RETINOBLASTOMA_PATHWAY_DN	23	22		
VERNELL_RETINOBLASTOMA_PATHWAY_UP	69	68		
VERNOCHET_ADIPOGENESIS	19	17		
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	37	35		
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	54	53		
VERRECCHIA_RESPONSE_TO_TGFB1_C1	19	19		
VERRECCHIA_RESPONSE_TO_TGFB1_C2	21	20		
VERRECCHIA_RESPONSE_TO_TGFB1_C3	14		Rejected!	
VERRECCHIA_RESPONSE_TO_TGFB1_C4	11		Rejected!	
VERRECCHIA_RESPONSE_TO_TGFB1_C5	21	21		
VERRECCHIA_RESPONSE_TO_TGFB1_C6	5		Rejected!	
VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	16		Rejected!	
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	16	16		
VICENT_METASTASIS_UP	14		Rejected!	
VIETOR_IFRD1_TARGETS	24	20		
VILIMAS_NOTCH1_TARGETS_DN	27	26		
VILIMAS_NOTCH1_TARGETS_UP	52	51		
VILLANUEVA_LIVER_CANCER_KRT19_DN	63	61		
VILLANUEVA_LIVER_CANCER_KRT19_UP	175	170		
VISALA_AGING_LYMPHOCYTE_DN	19	19		
VISALA_AGING_LYMPHOCYTE_UP	7		Rejected!	
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN	13		Rejected!	
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP	15	15		
WACKER_HYPOXIA_TARGETS_OF_VHL	13		Rejected!	
WAESCH_ANAPHASE_PROMOTING_COMPLEX	13		Rejected!	
WAGNER_APO2_SENSITIVITY	26	25		
WAGSCHAL_EHMT2_TARGETS_UP	14		Rejected!	
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR	29	29		
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D	646		Rejected!	
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	152	148		
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D	868		Rejected!	
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	148	148		
WAKASUGI_HAVE_ZNF143_BINDING_SITES	54	54		
WALLACE_JAK2_TARGETS_UP	23	21		
WALLACE_PROSTATE_CANCER_DN	6		Rejected!	
WALLACE_PROSTATE_CANCER_RACE_DN	86	84		
WALLACE_PROSTATE_CANCER_RACE_UP	303	298		
WALLACE_PROSTATE_CANCER_UP	20	20		
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	71	70		
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	140	137		
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	199	198		
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	270	258		
WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1	28	26		
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	37	31		
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	26	23		
WANG_BARRETTS_ESOPHAGUS_DN	25	22		
WANG_BARRETTS_ESOPHAGUS_UP	52	49		
WANG_CISPLATIN_RESPONSE_AND_XPC_DN	219	212		
WANG_CISPLATIN_RESPONSE_AND_XPC_UP	185	173		
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG	27	27		
WANG_CLIM2_TARGETS_DN	182	177		
WANG_CLIM2_TARGETS_UP	266	255		
WANG_ESOPHAGUS_CANCER_PROGRESSION_UP	9		Rejected!	
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	101	100		
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	121	120		
WANG_HCP_PROSTATE_CANCER	106	103		
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN	24	23		
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP	32	32		
WANG_LMO4_TARGETS_DN	361	345		
WANG_LMO4_TARGETS_UP	368	352		
WANG_LSD1_TARGETS_DN	37	34		
WANG_LSD1_TARGETS_UP	24	22		
WANG_METASTASIS_OF_BREAST_CANCER	16		Rejected!	
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN	32	31		
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	22	22		
WANG_METHYLATED_IN_BREAST_CANCER	35	33		
WANG_MLL_TARGETS	294	265		
WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC	22	20		
WANG_NFKB_TARGETS	24	20		
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	66	59		
WANG_RECURRENT_LIVER_CANCER_DN	16	15		
WANG_RECURRENT_LIVER_CANCER_UP	20	19		
WANG_RESPONSE_TO_ANDROGEN_UP	29	28		
WANG_RESPONSE_TO_BEXAROTENE_DN	30	28		
WANG_RESPONSE_TO_BEXAROTENE_UP	34	30		
WANG_RESPONSE_TO_FORSKOLIN_DN	9		Rejected!	
WANG_RESPONSE_TO_FORSKOLIN_UP	23	22		
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	371	367		
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP	392	379		
WANG_SMARCE1_TARGETS_DN	385	365		
WANG_SMARCE1_TARGETS_UP	294	281		
WANG_TARGETS_OF_MLL_CBP_FUSION_DN	46	44		
WANG_TARGETS_OF_MLL_CBP_FUSION_UP	45	40		
WANG_THOC1_TARGETS_DN	20	17		
WANG_THOC1_TARGETS_UP	5		Rejected!	
WANG_TNF_TARGETS	26	19		
WANG_TUMOR_INVASIVENESS_DN	211	203		
WANG_TUMOR_INVASIVENESS_UP	384	349		
WARTERS_IR_RESPONSE_5GY	50	48		
WARTERS_RESPONSE_TO_IR_SKIN	82	80		
WATANABE_COLON_CANCER_MSI_VS_MSS_DN	69	60		
WATANABE_COLON_CANCER_MSI_VS_MSS_UP	29	26		
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	93	90		
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	113	106		
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	15	15		
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	19	18		
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	43	37		
WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP	6		Rejected!	
WEBER_METHYLATED_HCP_IN_SPERM_DN	29	25		
WEBER_METHYLATED_HCP_IN_SPERM_UP	20	17		
WEBER_METHYLATED_ICP_IN_FIBROBLAST	21		Rejected!	
WEBER_METHYLATED_ICP_IN_SPERM_DN	13		Rejected!	
WEBER_METHYLATED_ICP_IN_SPERM_UP	8		Rejected!	
WEBER_METHYLATED_IN_COLON_CANCER	18		Rejected!	
WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN	10		Rejected!	
WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP	13		Rejected!	
WEBER_METHYLATED_LCP_IN_SPERM_DN	8		Rejected!	
WEBER_METHYLATED_LCP_IN_SPERM_UP	15		Rejected!	
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	36	36		
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	59	57		
WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	35	32		
WEIGEL_OXIDATIVE_STRESS_RESPONSE	33	33		
WEINMANN_ADAPTATION_TO_HYPOXIA_DN	38	37		
WEINMANN_ADAPTATION_TO_HYPOXIA_UP	26	26		
WEI_MIR34A_TARGETS	146	140		
WEI_MYCN_TARGETS_WITH_E_BOX	792		Rejected!	
WELCH_GATA1_TARGETS	25	24		
WELCSH_BRCA1_TARGETS_DN	141	139		
WELCSH_BRCA1_TARGETS_UP	201	197		
WENDT_COHESIN_TARGETS_UP	32	32		
WENG_POR_DOSAGE	23	22		
WENG_POR_TARGETS_GLOBAL_DN	25	23		
WENG_POR_TARGETS_GLOBAL_UP	19	19		
WENG_POR_TARGETS_LIVER_DN	23	19		
WENG_POR_TARGETS_LIVER_UP	42	42		
WESTON_VEGFA_TARGETS	95	88		
WESTON_VEGFA_TARGETS_12HR	27	25		
WESTON_VEGFA_TARGETS_3HR	66	60		
WESTON_VEGFA_TARGETS_6HR	50	44		
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	25	24		
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	21	19		
WEST_ADRENOCORTICAL_TUMOR_DN	546		Rejected!	
WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	20	18		
WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	22	22		
WEST_ADRENOCORTICAL_TUMOR_UP	298	293		
WHITEFORD_PEDIATRIC_CANCER_MARKERS	117	117		
WHITEHURST_PACLITAXEL_SENSITIVITY	38	37		
WHITESIDE_CISPLATIN_RESISTANCE_DN	13		Rejected!	
WHITESIDE_CISPLATIN_RESISTANCE_UP	11		Rejected!	
WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION	20	19		
WHITFIELD_CELL_CYCLE_G1_S	133	130		
WHITFIELD_CELL_CYCLE_G2	168	166		
WHITFIELD_CELL_CYCLE_G2_M	198	194		
WHITFIELD_CELL_CYCLE_LITERATURE	44	44		
WHITFIELD_CELL_CYCLE_M_G1	126	121		
WHITFIELD_CELL_CYCLE_S	150	148		
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2	57	53		
WIELAND_UP_BY_HBV_INFECTION	103	103		
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN	5		Rejected!	
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP	11		Rejected!	
WIERENGA_PML_INTERACTOME	42	37		
WIERENGA_STAT5A_TARGETS_DN	193	192		
WIERENGA_STAT5A_TARGETS_GROUP1	127	127		
WIERENGA_STAT5A_TARGETS_GROUP2	54	54		
WIERENGA_STAT5A_TARGETS_UP	202	202		
WIKMAN_ASBESTOS_LUNG_CANCER_DN	30	30		
WIKMAN_ASBESTOS_LUNG_CANCER_UP	17	17		
WILCOX_RESPONSE_TO_PROGESTERONE_DN	62	60		
WILCOX_RESPONSE_TO_PROGESTERONE_UP	153	146		
WILENSKY_RESPONSE_TO_DARAPLADIB	28	28		
WILLERT_WNT_SIGNALING	23	21		
WILLIAMS_ESR1_TARGETS_DN	6		Rejected!	
WILLIAMS_ESR1_TARGETS_UP	26	24		
WILLIAMS_ESR2_TARGETS_DN	11		Rejected!	
WILLIAMS_ESR2_TARGETS_UP	29	28		
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN	5		Rejected!	
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP	20	18		
WINNEPENNINCKX_MELANOMA_METASTASIS_DN	45	42		
WINNEPENNINCKX_MELANOMA_METASTASIS_UP	162	156		
WINTER_HYPOXIA_DN	52	52		
WINTER_HYPOXIA_METAGENE	243	228		
WINTER_HYPOXIA_UP	95	90		
WINZEN_DEGRADED_VIA_KHSRP	100	96		
WONG_ADULT_TISSUE_STEM_MODULE	721		Rejected!	
WONG_EMBRYONIC_STEM_CELL_CORE	335	306		
WONG_ENDMETRIUM_CANCER_DN	78	75		
WONG_ENDMETRIUM_CANCER_UP	25	19		
WONG_ENDOMETRIAL_CANCER_LATE	9		Rejected!	
WONG_MITOCHONDRIA_GENE_MODULE	218	193		
WONG_PROTEASOME_GENE_MODULE	50	50		
WOOD_EBV_EBNA1_TARGETS_DN	48	48		
WOOD_EBV_EBNA1_TARGETS_UP	110	107		
WOO_LIVER_CANCER_RECURRENCE_DN	78	75		
WOO_LIVER_CANCER_RECURRENCE_UP	105	103		
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN	14		Rejected!	
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP	31	28		
WORSCHECH_TUMOR_REJECTION_DN	10		Rejected!	
WORSCHECH_TUMOR_REJECTION_UP	61	54		
WOTTON_RUNX_TARGETS_DN	29	26		
WOTTON_RUNX_TARGETS_UP	20	18		
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN	13		Rejected!	
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	64	58		
WU_ALZHEIMER_DISEASE_DN	19	17		
WU_ALZHEIMER_DISEASE_UP	14		Rejected!	
WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53	11		Rejected!	
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	53	53		
WU_CELL_MIGRATION	183	170		
WU_HBX_TARGETS_1_DN	23	23		
WU_HBX_TARGETS_1_UP	16	16		
WU_HBX_TARGETS_2_DN	16	16		
WU_HBX_TARGETS_2_UP	23	23		
WU_HBX_TARGETS_3_DN	13		Rejected!	
WU_HBX_TARGETS_3_UP	18	18		
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	52	51		
XIE_LT_HSC_S1PR3_OE_UP	29	29		
XIE_ST_HSC_S1PR3_OE_DN	23	23		
XIE_ST_HSC_S1PR3_OE_UP	189	185		
XU_AKT1_TARGETS_48HR	9		Rejected!	
XU_AKT1_TARGETS_6HR	27	27		
XU_CREBBP_TARGETS_DN	39	38		
XU_CREBBP_TARGETS_UP	22	22		
XU_GH1_AUTOCRINE_TARGETS_DN	131	123		
XU_GH1_AUTOCRINE_TARGETS_UP	201	176		
XU_GH1_EXOGENOUS_TARGETS_DN	105	92		
XU_GH1_EXOGENOUS_TARGETS_UP	56	43		
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	19	19		
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	35	34		
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	25	25		
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	23	22		
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP	13		Rejected!	
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	19	19		
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	89	77		
XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP	10		Rejected!	
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	14		Rejected!	
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	15	15		
XU_RESPONSE_TO_TRETINOIN_DN	12		Rejected!	
XU_RESPONSE_TO_TRETINOIN_UP	16	15		
YAGI_AML_FAB_MARKERS	194	193		
YAGI_AML_RELAPSE_PROGNOSIS	35	34		
YAGI_AML_SURVIVAL	123	119		
YAGI_AML_WITH_11Q23_REARRANGED	344	332		
YAGI_AML_WITH_INV_16_TRANSLOCATION	411	365		
YAGI_AML_WITH_T_8_21_TRANSLOCATION	372	359		
YAGI_AML_WITH_T_9_11_TRANSLOCATION	131	124		
YAGUE_PRETUMOR_DRUG_RESISTANCE_DN	13		Rejected!	
YAGUE_PRETUMOR_DRUG_RESISTANCE_UP	8		Rejected!	
YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN	8		Rejected!	
YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP	11		Rejected!	
YAMASHITA_LIVER_CANCER_STEM_CELL_DN	76	63		
YAMASHITA_LIVER_CANCER_STEM_CELL_UP	47	43		
YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	17		Rejected!	
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	53	31		
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER	66	55		
YAMASHITA_SILENCED_BY_METHYLATION	8		Rejected!	
YAMAZAKI_TCEB3_TARGETS_DN	201	189		
YAMAZAKI_TCEB3_TARGETS_UP	166	163		
YANAGIHARA_ESX1_TARGETS	29	28		
YANAGISAWA_LUNG_CANCER_RECURRENCE	9		Rejected!	
YANG_BCL3_TARGETS_DN	8		Rejected!	
YANG_BCL3_TARGETS_UP	333	317		
YANG_BREAST_CANCER_ESR1_BULK_DN	22	20		
YANG_BREAST_CANCER_ESR1_BULK_UP	26	25		
YANG_BREAST_CANCER_ESR1_DN	24	24		
YANG_BREAST_CANCER_ESR1_LASER_DN	47	45		
YANG_BREAST_CANCER_ESR1_LASER_UP	32	29		
YANG_BREAST_CANCER_ESR1_UP	36	34		
YAN_ESCAPE_FROM_ANOIKIS	23	23		
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN	20	18		
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP	83	77		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	72	69		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	69	68		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	70	68		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	100	100		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12	80	78		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	178	166		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	143	137		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15	36	35		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16	79	73		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	184	169		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2	56	48		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3	22	22		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4	16	15		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	31	27		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	79	75		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	73	67		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	50	47		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9	78	74		
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN	250	204		
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP	147	132		
YEGNASUBRAMANIAN_PROSTATE_CANCER	135	111		
YEMELYANOV_GR_TARGETS_DN	11		Rejected!	
YIH_RESPONSE_TO_ARSENITE_C1	22	22		
YIH_RESPONSE_TO_ARSENITE_C2	14		Rejected!	
YIH_RESPONSE_TO_ARSENITE_C3	31	31		
YIH_RESPONSE_TO_ARSENITE_C4	17	17		
YIH_RESPONSE_TO_ARSENITE_C5	11		Rejected!	
YOKOE_CANCER_TESTIS_ANTIGENS	35	33		
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN	72	68		
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP	22	22		
YOSHIMURA_MAPK8_TARGETS_DN	379	364		
YOSHIMURA_MAPK8_TARGETS_UP	1282		Rejected!	
YUAN_ZNF143_PARTNERS	22	21		
YU_BAP1_TARGETS	29	29		
YU_MYC_TARGETS_DN	60	59		
YU_MYC_TARGETS_UP	43	43		
ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS	14		Rejected!	
ZAMORA_NOS2_TARGETS_DN	82	79		
ZAMORA_NOS2_TARGETS_UP	57	54		
ZEILSTRA_CD44_TARGETS_DN	9		Rejected!	
ZEILSTRA_CD44_TARGETS_UP	8		Rejected!	
ZERBINI_RESPONSE_TO_SULINDAC_DN	6		Rejected!	
ZERBINI_RESPONSE_TO_SULINDAC_UP	9		Rejected!	
ZHANG_ADIPOGENESIS_BY_BMP7	14		Rejected!	
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN	45	43		
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	28	26		
ZHANG_BREAST_CANCER_PROGENITORS_DN	139	136		
ZHANG_BREAST_CANCER_PROGENITORS_UP	433	426		
ZHANG_GATA6_TARGETS_DN	63	63		
ZHANG_GATA6_TARGETS_UP	16		Rejected!	
ZHANG_INTERFERON_RESPONSE	24	22		
ZHANG_PROLIFERATING_VS_QUIESCENT	49	47		
ZHANG_RESPONSE_TO_CANTHARIDIN_DN	67	62		
ZHANG_RESPONSE_TO_CANTHARIDIN_UP	15	15		
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	106	103		
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	223	215		
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	87	85		
ZHAN_EARLY_DIFFERENTIATION_GENES_DN	42	42		
ZHAN_EARLY_DIFFERENTIATION_GENES_UP	7		Rejected!	
ZHAN_LATE_DIFFERENTIATION_GENES_DN	17	17		
ZHAN_LATE_DIFFERENTIATION_GENES_UP	33	33		
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	55	54		
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	94	93		
ZHAN_MULTIPLE_MYELOMA_CD1_DN	47	46		
ZHAN_MULTIPLE_MYELOMA_CD1_UP	46	45		
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	53	53		
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	69	68		
ZHAN_MULTIPLE_MYELOMA_CD2_DN	47	44		
ZHAN_MULTIPLE_MYELOMA_CD2_UP	48	48		
ZHAN_MULTIPLE_MYELOMA_DN	42	41		
ZHAN_MULTIPLE_MYELOMA_HP_DN	47	47		
ZHAN_MULTIPLE_MYELOMA_HP_UP	50	45		
ZHAN_MULTIPLE_MYELOMA_LB_DN	40	40		
ZHAN_MULTIPLE_MYELOMA_LB_UP	47	46		
ZHAN_MULTIPLE_MYELOMA_MF_DN	43	43		
ZHAN_MULTIPLE_MYELOMA_MF_UP	48	47		
ZHAN_MULTIPLE_MYELOMA_MS_DN	45	42		
ZHAN_MULTIPLE_MYELOMA_MS_UP	50	50		
ZHAN_MULTIPLE_MYELOMA_PR_DN	49	49		
ZHAN_MULTIPLE_MYELOMA_PR_UP	46	43		
ZHAN_MULTIPLE_MYELOMA_SPIKED	24	20		
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	30	30		
ZHAN_MULTIPLE_MYELOMA_UP	64	64		
ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	16		Rejected!	
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	33	32		
ZHAN_V2_LATE_DIFFERENTIATION_GENES	45	45		
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	31	31		
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP	17	15		
ZHENG_BOUND_BY_FOXP3	498	490		
ZHENG_FOXP3_TARGETS_DN	6		Rejected!	
ZHENG_FOXP3_TARGETS_IN_THYMUS_DN	13		Rejected!	
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	199	198		
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	38	38		
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP	12		Rejected!	
ZHENG_FOXP3_TARGETS_UP	26	26		
ZHENG_GLIOBLASTOMA_PLASTICITY_DN	60	58		
ZHENG_GLIOBLASTOMA_PLASTICITY_UP	248	241		
ZHENG_IL22_SIGNALING_DN	41	38		
ZHENG_IL22_SIGNALING_UP	58	52		
ZHENG_RESPONSE_TO_ARSENITE_DN	12		Rejected!	
ZHENG_RESPONSE_TO_ARSENITE_UP	15		Rejected!	
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	71	68		
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	186	172		
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	67	65		
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	131	125		
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE	76	73		
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	127	126		
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR	8		Rejected!	
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	84	84		
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN	278	267		
ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	515	471		
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN	377	357		
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	450	414		
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	405	354		
ZHOU_PANCREATIC_BETA_CELL	11		Rejected!	
ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR	14		Rejected!	
ZHOU_PANCREATIC_EXOCRINE_PROGENITOR	11		Rejected!	
ZHOU_TNF_SIGNALING_30MIN	51	48		
ZHOU_TNF_SIGNALING_4HR	50	46		
ZHU_CMV_24_HR_DN	84	78		
ZHU_CMV_24_HR_UP	82	82		
ZHU_CMV_8_HR_DN	50	49		
ZHU_CMV_8_HR_UP	41	40		
ZHU_CMV_ALL_DN	119	112		
ZHU_CMV_ALL_UP	107	106		
ZHU_SKIL_TARGETS_DN	9		Rejected!	
ZHU_SKIL_TARGETS_UP	20	19		
ZIRN_TRETINOIN_RESPONSE_DN	6		Rejected!	
ZIRN_TRETINOIN_RESPONSE_UP	20	20		
ZIRN_TRETINOIN_RESPONSE_WT1_DN	6		Rejected!	
ZIRN_TRETINOIN_RESPONSE_WT1_UP	23	23		
ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	550	492		
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF	54	50		
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	232	227		
ZWANG_DOWN_BY_2ND_EGF_PULSE	322	295		
ZWANG_EGF_INTERVAL_DN	238	215		
ZWANG_EGF_INTERVAL_UP	112	93		
ZWANG_EGF_PERSISTENTLY_DN	62	58		
ZWANG_EGF_PERSISTENTLY_UP	34	33		
ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY	1959		Rejected!	
